JP5209816B1 - Method for producing O / W emulsion composition - Google Patents
Method for producing O / W emulsion composition Download PDFInfo
- Publication number
- JP5209816B1 JP5209816B1 JP2012204216A JP2012204216A JP5209816B1 JP 5209816 B1 JP5209816 B1 JP 5209816B1 JP 2012204216 A JP2012204216 A JP 2012204216A JP 2012204216 A JP2012204216 A JP 2012204216A JP 5209816 B1 JP5209816 B1 JP 5209816B1
- Authority
- JP
- Japan
- Prior art keywords
- emulsified
- oil
- mass
- aqueous phase
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 101
- 239000000839 emulsion Substances 0.000 title claims abstract description 91
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 28
- 239000008346 aqueous phase Substances 0.000 claims abstract description 70
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 62
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 45
- 239000012071 phase Substances 0.000 claims abstract description 37
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 36
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims abstract description 33
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 33
- 238000003756 stirring Methods 0.000 claims abstract description 12
- 238000002156 mixing Methods 0.000 claims abstract description 11
- 239000003921 oil Substances 0.000 claims description 55
- 238000001816 cooling Methods 0.000 claims description 24
- 125000005702 oxyalkylene group Chemical group 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 17
- 125000006353 oxyethylene group Chemical group 0.000 claims description 14
- 230000001804 emulsifying effect Effects 0.000 claims description 7
- 150000002430 hydrocarbons Chemical class 0.000 claims description 5
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 239000010696 ester oil Substances 0.000 claims description 4
- 229930195712 glutamate Natural products 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 229920002545 silicone oil Polymers 0.000 claims description 4
- 239000002245 particle Substances 0.000 abstract description 35
- 230000007613 environmental effect Effects 0.000 abstract description 6
- 235000019198 oils Nutrition 0.000 description 49
- -1 aralkyl alcohol Chemical compound 0.000 description 31
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 14
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 12
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- 238000004945 emulsification Methods 0.000 description 12
- 239000000194 fatty acid Substances 0.000 description 12
- 229930195729 fatty acid Natural products 0.000 description 12
- 150000004665 fatty acids Chemical class 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 229910052799 carbon Inorganic materials 0.000 description 10
- 239000002537 cosmetic Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- GOQYKNQRPGWPLP-UHFFFAOYSA-N heptadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 229960000735 docosanol Drugs 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- MACVUTCNLULHLQ-UHFFFAOYSA-N 2-[methyl(octadecanoyl)amino]ethanesulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O MACVUTCNLULHLQ-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 229940008099 dimethicone Drugs 0.000 description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 3
- 240000000912 Macadamia tetraphylla Species 0.000 description 3
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000003125 aqueous solvent Substances 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 3
- 229940049906 glutamate Drugs 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 229960003080 taurine Drugs 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 244000280244 Luffa acutangula Species 0.000 description 2
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IRHTZOCLLONTOC-UHFFFAOYSA-N hexacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCO IRHTZOCLLONTOC-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- IACKKVBKKNJZGN-UHFFFAOYSA-N pentacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCO IACKKVBKKNJZGN-UHFFFAOYSA-N 0.000 description 2
- REIUXOLGHVXAEO-UHFFFAOYSA-N pentadecan-1-ol Chemical compound CCCCCCCCCCCCCCCO REIUXOLGHVXAEO-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229940043230 sarcosine Drugs 0.000 description 2
- 235000019983 sodium metaphosphate Nutrition 0.000 description 2
- 229940074404 sodium succinate Drugs 0.000 description 2
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 2
- KKDONKAYVYTWGY-UHFFFAOYSA-M sodium;2-(methylamino)ethanesulfonate Chemical compound [Na+].CNCCS([O-])(=O)=O KKDONKAYVYTWGY-UHFFFAOYSA-M 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- TYWMIZZBOVGFOV-UHFFFAOYSA-N tetracosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCO TYWMIZZBOVGFOV-UHFFFAOYSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- FPLNRAYTBIFSFW-UHFFFAOYSA-N tricosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCO FPLNRAYTBIFSFW-UHFFFAOYSA-N 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- XFRVVPUIAFSTFO-UHFFFAOYSA-N 1-Tridecanol Chemical compound CCCCCCCCCCCCCO XFRVVPUIAFSTFO-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- AYUKNFXLSTVUAB-UHFFFAOYSA-N 2-[2-[2-(2,2-dimethylpropanoyloxy)propoxy]propoxy]propyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC(C)COC(C)COC(C)COC(=O)C(C)(C)C AYUKNFXLSTVUAB-UHFFFAOYSA-N 0.000 description 1
- WSRXLNLZLUNDKZ-UHFFFAOYSA-N 2-octadecanoyloxyethanesulfonic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCS(O)(=O)=O WSRXLNLZLUNDKZ-UHFFFAOYSA-N 0.000 description 1
- ADLFDNOTASDSPT-UHFFFAOYSA-N 2-tetradecanoyloxyethanesulfonic acid Chemical compound CCCCCCCCCCCCCC(=O)OCCS(O)(=O)=O ADLFDNOTASDSPT-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- JSCQSBGXKRTPHZ-UHFFFAOYSA-N Mucidin Natural products COC=C(C(=O)OC)C(C)=CC=CC1=CC=CC=C1 JSCQSBGXKRTPHZ-UHFFFAOYSA-N 0.000 description 1
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- KCFRUUYAXCDZNZ-UHFFFAOYSA-N N-dodecanoyltaurine Chemical class CCCCCCCCCCCC(=O)NCCS(O)(=O)=O KCFRUUYAXCDZNZ-UHFFFAOYSA-N 0.000 description 1
- LMIJIHJZVURGQK-UHFFFAOYSA-N N-stearoyltaurine Chemical class CCCCCCCCCCCCCCCCCC(=O)NCCS(O)(=O)=O LMIJIHJZVURGQK-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- JSCQSBGXKRTPHZ-WMSPMLHYSA-N Strobilurin A Natural products COC=C(/C(=C/C=C/c1ccccc1)/C)C(=O)OC JSCQSBGXKRTPHZ-WMSPMLHYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TUYRNAGGIJZRNM-LBHUVFDKSA-N [(2s)-2-[(2r)-4-hexadecanoyloxy-3-hydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=C1O TUYRNAGGIJZRNM-LBHUVFDKSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000012644 addition polymerization Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229940079840 cocoyl isethionate Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- VJZWIFWPGRIJSN-XRHABHTOSA-N dilinoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O.CCCCC\C=C/C\C=C/CCCCCCCC(O)=O VJZWIFWPGRIJSN-XRHABHTOSA-N 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- JSCQSBGXKRTPHZ-SYKZHUKTSA-N mucidin Chemical compound CO\C=C(\C(=O)OC)/C(/C)=C\C=C\C1=CC=CC=C1 JSCQSBGXKRTPHZ-SYKZHUKTSA-N 0.000 description 1
- 229940071146 myristoyl isethionate Drugs 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- XGFDHKJUZCCPKQ-UHFFFAOYSA-N n-nonadecyl alcohol Natural products CCCCCCCCCCCCCCCCCCCO XGFDHKJUZCCPKQ-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-MDZDMXLPSA-N oleyl alcohol Chemical compound CCCCCCCC\C=C\CCCCCCCCO ALSTYHKOOCGGFT-MDZDMXLPSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 238000000646 scanning calorimetry Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- KLIFRVSZGDONER-FERBBOLQSA-M sodium;(4s)-4-(hexadecanoylamino)-5-hydroxy-5-oxopentanoate Chemical compound [H+].[Na+].CCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O KLIFRVSZGDONER-FERBBOLQSA-M 0.000 description 1
- UKSFMDODPANKJI-UHFFFAOYSA-M sodium;2-[methyl(octadecanoyl)amino]ethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)N(C)CCS([O-])(=O)=O UKSFMDODPANKJI-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 229940098385 triisostearin Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 229960005066 trisodium edetate Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/017—Mixtures of compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/02—Alkyl sulfonates or sulfuric acid ester salts derived from monohydric alcohols
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/28—Aminocarboxylic acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
【課題】水中でα−ゲルを形成するアニオン性界面活性剤と高級脂肪族アルコールとを用い、微細な乳化粒子径を有するO/W乳化組成物を簡便性、経済性、環境適合性に優れた方法で提供する。
【解決手段】本発明にかかるO/W乳化組成物の製造方法は、(A)炭素数12〜26の高級脂肪族アルコールと、(B)油分と、を含む油相と、(C)前記(A)と水中でα−ゲルを形成し得るアニオン性界面活性剤と、(D)特定のアルキレンオキシド誘導体と、(E)水と、を含む水相の一部(第1水相)とを、80℃以上の温度で乳化してO/W乳化パーツを調製する工程と、前記乳化パーツを10〜35℃の残りの水相(第2水相)と攪拌しながら混合することにより冷却する工程と、を含み、前記(D)アルキレンオキシド誘導体が前記乳化パーツ中1〜30質量%であることを特徴とする。
【選択図】 なしAn O / W emulsified composition having a fine emulsified particle size using an anionic surfactant that forms an α-gel in water and a higher aliphatic alcohol is excellent in simplicity, economy, and environmental compatibility. Provide in a different way.
A method for producing an O / W emulsion composition according to the present invention comprises: (A) an oil phase containing a higher aliphatic alcohol having 12 to 26 carbon atoms, and (B) an oil component; A part of an aqueous phase (first aqueous phase) comprising (A) an anionic surfactant capable of forming an α-gel in water, (D) a specific alkylene oxide derivative, and (E) water. Is cooled by mixing the emulsified part with the remaining aqueous phase (second aqueous phase) at 10 to 35 ° C. while stirring the mixture at a temperature of 80 ° C. or higher to prepare an O / W emulsified part. And (D) the alkylene oxide derivative is 1 to 30% by mass in the emulsified part.
[Selection figure] None
Description
本発明は、O/W乳化組成物の製造方法、特に水中でα−ゲルを形成するアニオン性界面活性剤と高級脂肪族アルコールとを用いたO/W乳化組成物について、簡便性、経済性、環境適合性に優れた方法で乳化粒子径が微細なO/W乳化組成物を製造可能な方法に関する。 The present invention relates to a method for producing an O / W emulsion composition, in particular, an O / W emulsion composition using an anionic surfactant that forms an α-gel in water and a higher aliphatic alcohol. The present invention relates to a method capable of producing an O / W emulsion composition having a fine emulsion particle diameter by a method having excellent environmental compatibility.
従来より、高級アルコールとアニオン性界面活性剤とが水中で形成するα−ゲルを用いたO/W乳化組成物が、化粧料や医薬品、医薬部外品などの外用組成物に用いられている(特許文献1〜4)。 Conventionally, O / W emulsion compositions using α-gel formed in water by higher alcohols and anionic surfactants are used in external compositions such as cosmetics, pharmaceuticals, and quasi drugs. (Patent Documents 1 to 4).
このようなO/W乳化組成物を調製する方法としては、通常、アニオン性界面活性剤を溶解した80℃以上の水相に、高級脂肪族アルコールを溶解した80℃以上の油相を加えてホモゲナイザー等で乳化したものをオンレーターなどの冷却機で35℃付近まで冷却する方法が用いられてきた。このようなO/W乳化組成物では、高温の油滴である乳化粒子中に溶解していた高級脂肪族アルコールが、冷却による温度低下とともに乳化粒子表面に出てきて水中に存在するアニオン性界面活性剤とともに会合体(α−ゲル)を形成して乳化粒子界面を取り囲み、O/W乳化組成物の安定化に寄与している(非特許文献1)。 As a method for preparing such an O / W emulsion composition, an oil phase of 80 ° C. or higher in which a higher aliphatic alcohol is dissolved is usually added to an aqueous phase of 80 ° C. or higher in which an anionic surfactant is dissolved. The method of cooling what was emulsified with the homogenizer etc. to about 35 degreeC with coolers, such as an onlator, has been used. In such an O / W emulsified composition, the higher aliphatic alcohol dissolved in the emulsified particles that are high-temperature oil droplets emerges on the surface of the emulsified particles as the temperature decreases due to cooling, and is present in the water. An aggregate (α-gel) is formed together with the active agent to surround the interface of the emulsified particles and contribute to the stabilization of the O / W emulsion composition (Non-patent Document 1).
しかしながら、このような80℃以上で乳化後、冷却という従来の方法では、成分の加熱や熱交換機の使用によりエネルギーを要するために無駄が多い。また、オンレーター等の冷却機の使用後の洗浄に多量の水を使うこととなり、環境負荷が高くなる。 However, the conventional method of cooling after emulsification at 80 ° C. or higher is wasteful because it requires energy by heating components or using a heat exchanger. In addition, a large amount of water is used for cleaning after use of a cooler such as an onlator, resulting in a high environmental load.
従って、従来のように全成分を加熱したり、オンレーター等の冷却装置を用いたりすることなく、O/W乳化組成物を経済的且つ容易に製造することができる方法を開発することが望まれていた。 Therefore, it is hoped to develop a method that can economically and easily produce an O / W emulsion composition without heating all components or using a cooling device such as an ontrator as in the prior art. It was rare.
近年、非イオン性界面活性剤と、前記非イオン性界面活性剤とともに水中でα−ゲルを形成し得る直鎖状高級アルコールと、油分と、を含む油相と、水相の一部とを70℃以上で乳化して高濃度のO/W乳化パーツを調製し、この乳化パーツを攪拌しながら10〜35℃の残部水相と混合してO/W乳化組成物を製造する方法が報告されている(特許文献5)。
この方法は、全成分を加熱する必要がなく、オンレーター等の冷却装置を使用せずにO/W乳化組成物が製造できるので、簡便性、経済性、環境適合性に優れている。
In recent years, an oil phase comprising a nonionic surfactant, a linear higher alcohol capable of forming an α-gel in water together with the nonionic surfactant, an oil component, and a part of the aqueous phase A method for preparing an O / W emulsified composition by emulsifying at 70 ° C or higher to prepare a high concentration O / W emulsified part and mixing the emulsified part with the remaining aqueous phase at 10 to 35 ° C while stirring is reported. (Patent Document 5).
This method does not need to heat all components and can produce an O / W emulsion composition without using a cooling device such as an on-lator, and thus is excellent in simplicity, economy, and environmental compatibility.
しかしながら、特許文献5には水中でα−ゲルを形成し得るアニオン性界面活性剤と高級脂肪酸アルコールとを用いた場合については検討されていなかった。
そして、本発明者らが検討したところ、水中でα−ゲルを形成し得るアニオン性界面活性剤と高級脂肪族アルコール、油分、ならびに水相の一部を用いて高濃度のO/W乳化パーツを調製し、この乳化パーツに低温の残部水相を混合して冷却してO/W乳化組成物を得ようとした場合には、微細な乳化粒子径のO/W乳化組成物を得ることが非常に困難であることが判明した。
However, Patent Document 5 has not studied a case where an anionic surfactant capable of forming an α-gel in water and a higher fatty acid alcohol are used.
And when the present inventors examined, an anionic surfactant which can form an alpha gel in water, a higher aliphatic alcohol, an oil component, and a high concentration O / W emulsified part using a part of water phase When an O / W emulsified composition is obtained by mixing and cooling the emulsified part with a low-temperature remaining aqueous phase and cooling it, an O / W emulsified composition having a fine emulsified particle diameter is obtained. Turned out to be very difficult.
本発明は、上記背景技術の事情に鑑みなされたものであり、その目的は、水中でα−ゲルを形成するアニオン性界面活性剤と高級脂肪族アルコールとを用い、微細な乳化粒子径を有するO/W乳化組成物を簡便性、経済性、環境適合性に優れた方法で提供することにある。 The present invention has been made in view of the circumstances of the background art described above, and its purpose is to use an anionic surfactant that forms an α-gel in water and a higher aliphatic alcohol, and has a fine emulsion particle size. The object is to provide an O / W emulsified composition by a method excellent in convenience, economy and environmental compatibility.
本発明者等が検討を行なった結果、水中でα−ゲルを形成し得るアニオン性界面活性剤と高級脂肪族アルコール、油分、ならびに水相の一部を用いて高濃度のO/W乳化パーツを調製する際に、特定量のアルキレンオキシド誘導体を用い、この乳化パーツに低温の残部水相を混合して冷却してO/W乳化組成物を調製した場合には、微細な乳化粒子径のO/W乳化組成物が得られることを見出し、本発明を完成するに至った。 As a result of studies by the present inventors, an anionic surfactant capable of forming an α-gel in water, a higher aliphatic alcohol, an oil component, and a high concentration O / W emulsified part using a part of the aqueous phase When preparing an O / W emulsified composition by using a specific amount of alkylene oxide derivative and mixing the emulsified part with a low-temperature remaining aqueous phase and cooling to prepare a fine emulsified particle size The inventors have found that an O / W emulsion composition can be obtained, and have completed the present invention.
すなわち、本発明にかかるO/W乳化組成物の製造方法は、
(A)炭素数12〜26の高級脂肪族アルコールと、
(B)油分と、
(C)前記(A)と水中でα−ゲルを形成し得るアニオン性界面活性剤と、
(D)下記一般式(1)で示されるアルキレンオキシド誘導体と、
(E)水と、
を含むO/W乳化組成物の製造方法であって、
(A)炭素数12〜26の高級脂肪族アルコールはO/W乳化組成物中0.05〜10質量%であり、
(B)油分は、炭化水素油、エステル油、シリコーン油から選ばれる1種以上を含有し、且つO/W乳化組成物中0.1〜20質量%であり、
(C)前記(A)と水中でα−ゲルを形成し得るアニオン性界面活性剤は、N−アシルスルホン酸塩型アニオン性界面活性剤及びN−アシルグルタミン酸塩型アニオン性界面活性剤から選ばれる1種以上で、且つO/W乳化組成物中0.01〜5質量%であり、
(A)炭素数12〜26の高級脂肪族アルコールと(C)アニオン性界面活性剤との合計量が、(B)油分10質量部に対して0.5〜10質量部であり、
(A)炭素数12〜26の高級脂肪族アルコールと、
(B)油分と、
を含む油相と、
(C)前記(A)と水中でα−ゲルを形成し得るアニオン性界面活性剤と、
(D)下記一般式(1)で示されるアルキレンオキシド誘導体と、
(E)水の一部と、
を含む第1水相とを、80℃以上の温度で乳化してO/W乳化パーツを調製する工程と、
前記乳化パーツを10〜35℃の残りの(E)水を含む第2水相と攪拌しながら混合することにより冷却する工程と、を含み、
前記(D)アルキレンオキシド誘導体が前記乳化パーツ中1〜30質量%であることを特徴とするO/W乳化組成物の製造方法である。
That is, the method for producing an O / W emulsion composition according to the present invention includes:
(A) a higher aliphatic alcohol having 12 to 26 carbon atoms;
(B) oil and
(C) an anionic surfactant capable of forming an α-gel in water with the (A),
(D) an alkylene oxide derivative represented by the following general formula (1);
(E) water and
A method for producing an O / W emulsion composition comprising
(A) The higher aliphatic alcohol having 12 to 26 carbon atoms is 0.05 to 10% by mass in the O / W emulsion composition,
(B) Oil content contains 1 or more types chosen from hydrocarbon oil, ester oil, and silicone oil, and is 0.1-20 mass% in O / W emulsion composition,
(C) The anionic surfactant capable of forming an α-gel in water with (A) is selected from N-acyl sulfonate type anionic surfactants and N-acyl glutamate type anionic surfactants. One or more selected from 0.01 to 5% by mass in the O / W emulsion composition,
(A) The total amount of the higher aliphatic alcohol having 12 to 26 carbon atoms and (C) the anionic surfactant is 0.5 to 10 parts by mass with respect to 10 parts by mass of (B) oil,
(A) a higher aliphatic alcohol having 12 to 26 carbon atoms;
(B) oil and
An oil phase containing,
(C) an anionic surfactant capable of forming an α-gel in water with the (A),
(D) an alkylene oxide derivative represented by the following general formula (1);
(E) a part of water,
A step of preparing an O / W emulsified part by emulsifying a first aqueous phase containing
Cooling the emulsified part by mixing with stirring the second aqueous phase containing the remaining (E) water at 10 to 35 ° C., and
The (D) alkylene oxide derivative is 1 to 30% by mass in the emulsified part, and is a method for producing an O / W emulsion composition.
R1O−[(AO)m(EO)n]−R2 (1)
(式中、AOは炭素数3〜4のオキシアルキレン基、EOはオキシエチレン基、mおよびnはそれぞれ前記オキシアルキレン基、オキシエチレン基の平均付加モル数で、1≦m≦70、1≦n≦70である。炭素数3〜4のオキシアルキレン基とオキシエチレン基の合計に対するオキシアルキレン基の割合は、20〜80重量%である。炭素数3〜4のオキシアルキレン基とオキシエチレン基はランダム状に付加している。R1,R2は、同一もしくは異なってもよい炭素数1〜4のアルキル基である。)
R 1 O - [(AO) m (EO) n] -R 2 (1)
(In the formula, AO is an oxyalkylene group having 3 to 4 carbon atoms, EO is an oxyethylene group, m and n are average addition moles of the oxyalkylene group and oxyethylene group, respectively, 1 ≦ m ≦ 70, 1 ≦ n ≦ 70 The ratio of the oxyalkylene group to the total of the oxyalkylene group having 3 to 4 carbon atoms and the oxyethylene group is 20 to 80% by weight, and the oxyalkylene group and oxyethylene group having 3 to 4 carbon atoms. is .R 1, R 2, appended to the random form is the same or different and an alkyl group having 1 to 4 carbon atoms.)
また、本発明は、前記何れかに記載の方法において、前記第2水相がO/W乳化組成物全量中40〜75質量%であることを特徴とするO/W乳化組成物の製造方法を提供する。 Moreover, this invention is the method in any one of the said, The said 2nd aqueous phase is 40-75 mass% in O / W emulsion composition whole quantity, The manufacturing method of the O / W emulsion composition characterized by the above-mentioned. Provide .
本発明の方法によれば、目的とするO/W乳化組成物の全成分を加熱する必要がなく、また、オンレーター等の冷却装置も使用せずにO/W乳化組成物が製造できるので、簡便性、経済性、環境適合性に優れている。そして、乳化パーツを調製する第1水相中に特定量のアルキレンオキシド誘導体を含むことにより、微細な乳化粒子径のO/W乳化組成物を容易に得ることができる。 According to the method of the present invention, it is not necessary to heat all the components of the target O / W emulsion composition, and an O / W emulsion composition can be produced without using a cooling device such as an onlator. Excellent in convenience, economy and environmental compatibility. And the O / W emulsion composition of a fine emulsion particle diameter can be easily obtained by including a specific amount of alkylene oxide derivative in the 1st water phase which prepares an emulsification part.
本発明にかかるO/W乳化組成物の製造方法は、油相が水相中に乳化されたO/W乳化組成物の製造方法において、次の第1工程及び第2工程を含むことを一つの特徴とする。
(1)第1工程(高濃度乳化パーツ調製工程):
油相と、水相の一部(第1水相)とを80℃以上の温度で乳化してO/W乳化パーツを調製する工程。
(2)第2工程(冷却工程):
前記乳化パーツと10〜35℃の残部水相(第2水相)とを攪拌しながら混合することにより冷却する工程。
前記油相は、(A)炭素数12〜26の高級脂肪族アルコールと、(B)油分と、を含む。
前記第1水相には、(C)前記(A)と水中でα−ゲルを形成するアニオン性界面活性剤と、(D)アルキレンオキシド誘導体と、(E)水と、を含む。
The method for producing an O / W emulsion composition according to the present invention includes the following first step and second step in the method for producing an O / W emulsion composition in which an oil phase is emulsified in an aqueous phase. With one feature.
(1) 1st process (high concentration emulsified parts preparation process):
A step of preparing an O / W emulsified part by emulsifying an oil phase and a part of the aqueous phase (first aqueous phase) at a temperature of 80 ° C. or higher.
(2) Second step (cooling step):
The step of cooling by mixing the emulsified part and the remaining aqueous phase (second aqueous phase) at 10 to 35 ° C. while stirring.
The oil phase contains (A) a higher aliphatic alcohol having 12 to 26 carbon atoms and (B) an oil component.
The first aqueous phase contains (C) an anionic surfactant that forms an α-gel in water with (A), (D) an alkylene oxide derivative, and (E) water.
また、本発明の方法においては、前記(D)アルキレンオキシド誘導体を、前記乳化パーツ中1〜30質量%、好ましくは3〜25質量%含むことも特徴とする。
このようにして得られたO/W乳化組成物の乳化粒子界面にはα−ゲルが形成されている。α−ゲルは、水との共存下において、界面活性剤が高級アルコールとともに形成する、ラメラ状の2分子膜からなる会合体のことをいう。
In the method of the present invention, the (D) alkylene oxide derivative is also contained in the emulsified part in an amount of 1 to 30% by mass, preferably 3 to 25% by mass.
An α-gel is formed at the emulsion particle interface of the thus obtained O / W emulsion composition. The α-gel refers to an aggregate composed of a lamellar bimolecular film formed by a surfactant together with a higher alcohol in the presence of water.
従来、(A)高級脂肪族アルコールとを含む油相と、(C)前記(A)と水中でα−ゲルを形成し得るアニオン性界面活性剤を含む水相とを、80℃以上の温度で乳化し、これを冷却する工程によりO/W乳化組成物が得られていたが、加熱や熱交換機の使用によりエネルギーの無駄が多い、オンレーター等の冷却装置を用いると経済的・環境的に負荷がかかってしまうという問題があった。 Conventionally, an oil phase containing (A) a higher aliphatic alcohol, and (C) an aqueous phase containing (A) and an anionic surfactant capable of forming an α-gel in water at a temperature of 80 ° C. or higher. O / W emulsified composition was obtained by the process of emulsifying and cooling this. However, it is economical and environmentally friendly if a cooling device such as an on-lator is used. There was a problem that would be loaded.
これに対して、本発明においては、目的とするO/W乳化組成物の水相成分の一部(第1水相)と油相成分とを用いて高濃度に乳化されたO/W乳化パーツを80℃以上(好ましくは80〜85℃)で調製し、上記乳化パーツと10〜35℃の低温の残りの水相成分(第2水相)とを攪拌しながら徐々に混合する。これにより、高温乳化パーツが希釈されるとともに冷却され、高温の乳化パーツの乳化粒子中に溶解していた高級脂肪族アルコールが出てきて乳化粒子界面でアニオン性界面活性剤及び水とともにα−ゲルを形成し、O/W乳化組成物が得られる。なお、乳化温度が80℃未満であると、乳化パーツが溶解しない場合がある。乳化、攪拌などに用いる装置は通常使用されているものから適宜選択すればよく、それまで使用していた装置をそのまま利用することができ、特別の設備は不要である。乳化パーツと第2水相との混合順序は特に制限されない。 On the other hand, in the present invention, O / W emulsification emulsified at a high concentration using a part of the aqueous phase component (first aqueous phase) of the target O / W emulsion composition and the oil phase component. The parts are prepared at 80 ° C. or higher (preferably 80 to 85 ° C.), and the emulsified parts and the remaining low-temperature aqueous phase component (second aqueous phase) at 10 to 35 ° C. are gradually mixed with stirring. As a result, the high-temperature emulsified part is diluted and cooled, and the higher aliphatic alcohol dissolved in the emulsified particles of the high-temperature emulsified part comes out, and the α-gel together with the anionic surfactant and water at the emulsified particle interface And an O / W emulsion composition is obtained. When the emulsification temperature is less than 80 ° C., the emulsified parts may not be dissolved. An apparatus used for emulsification, stirring and the like may be appropriately selected from those normally used, and the apparatus used so far can be used as it is, and no special equipment is required. The mixing order of the emulsified part and the second aqueous phase is not particularly limited.
よって、本発明の製造方法によれば、乳化の際、オンレーターなどの冷却機を用いることなく、多量の水相を加熱する必要もないため、低エネルギーで容易にO/W乳化組成物を製造することができる。
そして、本発明においては、(D)アルキレンオキシド誘導体を乳化パーツ中1〜30質量%、好ましくは3〜25質量%とすることで、得られたO/W乳化組成物の乳化粒子径を10μm以下、さらには5μm以下に微細化することができる。乳化パーツ中のアルキレンオキシド誘導体が少なすぎても多すぎても微細な乳化粒子径のO/W乳化組成物が得られない。また、アルキレンオキシド誘導体の代わりに他の水性溶媒を用いても、微細なO/W乳化組成物を得ることはできない。
Therefore, according to the production method of the present invention, it is not necessary to heat a large amount of the aqueous phase without using a cooler such as an onlator during emulsification. Can be manufactured.
And in this invention, the emulsion particle diameter of the obtained O / W emulsion composition is 10 micrometers by making (D) alkylene oxide derivative into 1-30 mass% in an emulsification part, Preferably it is 3-25 mass%. Thereafter, it can be further refined to 5 μm or less. If the alkylene oxide derivative in the emulsified part is too little or too much, an O / W emulsion composition having a fine emulsion particle size cannot be obtained. Even if another aqueous solvent is used in place of the alkylene oxide derivative, a fine O / W emulsion composition cannot be obtained.
以上のように、本発明にかかるO/W乳化組成物の製造方法は、特定量のアルキレンオキシド誘導体を用いて予め80℃以上で製造した高濃度のO/W乳化パーツに、10〜35℃の残部水相を添加するだけで、微細な乳化粒子径のO/W乳化組成物を得ることができるため、従来用いられてきた製造工程を大幅に簡素化でき、経済性、環境適合性にも優れている。
以下、本発明で用いる成分について説明する。
As mentioned above, the manufacturing method of the O / W emulsion composition concerning this invention is 10-35 degreeC in the high concentration O / W emulsion part manufactured previously at 80 degreeC or more using the specific amount alkylene oxide derivative. By simply adding the remaining aqueous phase, an O / W emulsion composition having a fine emulsified particle size can be obtained, so that the production process that has been used in the past can be greatly simplified, making it economical and environmentally compatible. Is also excellent.
Hereinafter, the components used in the present invention will be described.
<(A)炭素数12〜26の高級脂肪族アルコール>
本発明において、(A)成分である炭素数12〜26の高級脂肪族アルコールは、後述する(C)成分のアニオン性界面活性剤と、水中においてα−ゲルを形成する成分である。
なお、水中でα−ゲルを形成することは、DSC(示査走査型熱量測定)により確認することができる。すなわち、α−ゲルを形成する高級脂肪族アルコールとアニオン性界面活性剤を水と混合して得られる試料の吸熱ピークは、高級脂肪族アルコールとアニオン性界面活性剤をそれぞれを単独に水に溶解または分散させた試料で得られる吸熱ピークよりも高温側に単一のピークを示すことから、α−ゲルの形成を確認することができる。
<(A) Higher aliphatic alcohol having 12 to 26 carbon atoms>
In the present invention, the higher aliphatic alcohol having 12 to 26 carbon atoms, which is the component (A), is a component that forms an α-gel in water with the anionic surfactant as the component (C) described later.
The formation of α-gel in water can be confirmed by DSC (inspection scanning calorimetry). That is, the endothermic peak of a sample obtained by mixing a higher aliphatic alcohol and an anionic surfactant that form an α-gel with water dissolves the higher aliphatic alcohol and the anionic surfactant in water independently. Alternatively, since a single peak is shown on the higher temperature side than the endothermic peak obtained with the dispersed sample, formation of α-gel can be confirmed.
本発明に用いる高級脂肪族アルコールとしては、一般に化粧品、医薬品、医薬部外品などの外用組成物に用いられるものが挙げられる。例えば、飽和直鎖一価アルコールとしては、ドデカノール(=ラウリルアルコール)、トリデカノール、テトラデカノール(=ミリスチルアルコール)、ペンタデカノール、ヘキサデカノール(=セチルアルコール)、ヘプタデカノール、オクタデカノール(=ステアリルアルコール)、ノナデカノール、イコサノール(=アラキルアルコール)、ヘンイコサノール、ドコサノール(=ベヘニルアルコール)、トリコサノール、テトラコサノール(=カルナービルアルコール)、ペンタコサノール、ヘキサコサノール(=セリルアルコール)等が挙げられる。不飽和一価アルコールとしてはエライジルアルコール等が挙げられる。経時安定性の点からは、炭素数12〜26(好ましくは炭素数18〜22)の飽和直鎖一価アルコールが好ましい。 Examples of the higher aliphatic alcohol used in the present invention include those generally used for external compositions such as cosmetics, pharmaceuticals, and quasi drugs. For example, saturated linear monohydric alcohols include dodecanol (= lauryl alcohol), tridecanol, tetradecanol (= myristyl alcohol), pentadecanol, hexadecanol (= cetyl alcohol), heptadecanol, octadecanol ( = Stearyl alcohol), nonadecanol, icosanol (= aralkyl alcohol), heicosanol, docosanol (= behenyl alcohol), tricosanol, tetracosanol (= carnerville alcohol), pentacosanol, hexacosanol (= seryl alcohol) It is done. Examples of unsaturated monohydric alcohols include elaidyl alcohol. From the viewpoint of stability over time, a saturated linear monohydric alcohol having 12 to 26 carbon atoms (preferably 18 to 22 carbon atoms) is preferable.
(A)高級脂肪族アルコールは1種または2種以上を用いることができ、好ましくは2種以上の高級脂肪族アルコールの混合物が用いられる。O/W乳化組成物の温度安定性の点からは、その混合物の融点が60℃以上となるような組合せがより好ましい。好適な組み合わせの一例としては、ステアリルアルコールとベヘニルアルコールの組合せが挙げられる。 (A) 1 type (s) or 2 or more types can be used for a higher aliphatic alcohol, Preferably the mixture of 2 or more types of higher aliphatic alcohol is used. From the viewpoint of temperature stability of the O / W emulsion composition, a combination such that the melting point of the mixture is 60 ° C. or higher is more preferable. An example of a suitable combination is a combination of stearyl alcohol and behenyl alcohol.
(A)高級脂肪族アルコールは、炭素数算術平均により得られる平均炭素数が18以上であることが望ましい。平均炭素数が18未満である場合には、O/W乳化組成物の融点が低くなり、高温安定性が十分でない場合がある。なお平均炭素数の上限値は特に限定されるものではないが、炭素数22程度とするのが好ましい。
本発明において、(A)高級脂肪族アルコールの配合量は、通常、O/W乳化組成物全量中、0.05〜10質量%、好ましくは0.1〜6質量%である。
(A) As for higher aliphatic alcohol, it is desirable for the average carbon number obtained by a carbon number arithmetic average to be 18 or more. When the average carbon number is less than 18, the melting point of the O / W emulsion composition becomes low, and the high temperature stability may not be sufficient. The upper limit of the average carbon number is not particularly limited, but is preferably about 22 carbon atoms.
In this invention, the compounding quantity of (A) higher aliphatic alcohol is 0.05-10 mass% normally in the O / W emulsion composition whole quantity, Preferably it is 0.1-6 mass%.
<(B)油分>
本発明に用いる油分は特に限定されず、一般に化粧品、医薬品、医薬部外品などの外用組成物に用いられているものが好適に用いられる。例えば、炭化水素油、エステル油などの極性油、シリコーン油、液体油脂等が好ましいが、これらに限定されるものではない。
<(B) Oil>
The oil component used in the present invention is not particularly limited, and those generally used in external compositions such as cosmetics, pharmaceuticals, and quasi drugs are preferably used. For example, polar oils such as hydrocarbon oils and ester oils, silicone oils, liquid oils and the like are preferable, but not limited thereto.
炭化水素油としては、流動パラフィン、スクワラン、スクワレン、パラフィン、イソパラフィン、セレシン等が挙げられる。 Examples of the hydrocarbon oil include liquid paraffin, squalane, squalene, paraffin, isoparaffin, ceresin and the like.
シリコーン油としては、例えばジメチルポリシロキサン、メチルフェニルポリシロキサン、メチルハイドロジェンポリシロキサン等の鎖状シリコーン;オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン等の環状シリコーン;3次元網目構造を形成しているシリコ−ン樹脂、シリコーンゴムなどが例示される。 Examples of the silicone oil include chain silicones such as dimethylpolysiloxane, methylphenylpolysiloxane, and methylhydrogenpolysiloxane; cyclic silicones such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and dodecamethylcyclohexasiloxane; Examples thereof include silicone resin and silicone rubber forming a network structure.
エステル油などの極性油としては、テトラエチルヘキサン酸ペンタエリスリチル、エチルヘキサン酸セチル、ホホバ油、ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)、トリイソステアリン、ジイソステアリン酸グリセリル、トリエチルヘキサノイン、ダイマージリノール酸(フィトステリル/ベヘニル)、ダイマージリノール酸(フィトステリル/イソステアリル/セチル/ステアリル/ベヘニル)、パルミチン酸イソプロピル、マカデミアナッツ脂肪酸フィトステリル、テトラ(ベヘン酸/安息香酸/エチルヘキサン酸)ペンタエリスリチル、パルミチン酸エチルヘキシル、ミリスチン酸ミリスチル、ジピバリン酸トリプロピレングリコール等が挙げられる。 Polar oils such as ester oils include pentaerythrityl tetraethylhexanoate, cetyl ethylhexanoate, jojoba oil, dilauroyl glutamate (phytosteryl / octyldodecyl), triisostearin, glyceryl diisostearate, triethylhexanoin, dimer dilinoleic acid ( Phytosteryl / behenyl), dimer linoleic acid (phytosteryl / isostearyl / cetyl / stearyl / behenyl), isopropyl palmitate, macadamia nut fatty acid phytosteryl, tetra (behenic acid / benzoic acid / ethylhexanoic acid) pentaerythrityl, ethylhexyl palmitate, Examples include myristyl myristate and tripropylene glycol dipivalate.
液体油脂としては、アマニ油、ツバキ油、マカデミアナッツ油、トウモロコシ油、ミンク油、オリーブ油、アボカド油、サザンカ油、ヒマシ油、サフラワー油、ヒマワリ油、アルモンド油、ナタネ油、ゴマ油、大豆油、落花生油、トリグリセリン、トリオクタン酸グリセリン、トリイソパルミチン酸グリセリン等が挙げられる。 Liquid oils include linseed oil, camellia oil, macadamia nut oil, corn oil, mink oil, olive oil, avocado oil, sasanqua oil, castor oil, safflower oil, sunflower oil, almond oil, rapeseed oil, sesame oil, soybean oil, peanut Examples thereof include oil, triglycerin, glycerin trioctanoate, and glycerin triisopalmitate.
油分は、1種または2種以上を併用して用いることも可能である。
本発明において、油分の配合量としては特に限定されるものではないが、通常は、O/W乳化組成物全量中0.1〜20質量%、好ましくは0.2〜15質量%である。
The oil can be used alone or in combination of two or more.
In the present invention, the blending amount of the oil is not particularly limited, but is usually 0.1 to 20% by mass, preferably 0.2 to 15% by mass in the total amount of the O / W emulsion composition.
<(C)アニオン性界面活性剤>
本発明において、(C)成分のアニオン性界面活性剤は、上記(A)成分の高級脂肪族アルコールと、水中においてα−ゲルを形成する成分である。
<(C) Anionic surfactant>
In the present invention, the anionic surfactant of component (C) is a component that forms an α-gel in water with the higher aliphatic alcohol of component (A).
本発明に用いるアニオン性界面活性剤は、一般に化粧品、医薬品、医薬部外品などの外用組成物に用いられているものが挙げられる。例えば、脂肪酸セッケン(例えば、ラウリン酸ナトリウム、パルミチン酸ナトリウム等);高級アルキル硫酸エステル塩(例えば、ラウリル硫酸ナトリウム、ラウリル硫酸カリウム等);アルキルエーテル硫酸エステル塩(例えば、POE−ラウリル硫酸トリエタノールアミン、POE−ラウリル硫酸ナトリウム等);N−アシルサルコシン酸(例えば、ラウロイルサルコシンナトリウム等);高級脂肪酸アミドスルホン酸塩(例えば、N−ミリストイル−N−メチルタウリンナトリウム、ヤシ油脂肪酸メチルタウリンナトリウム、ラウリルメチルタウリンナトリウム等);リン酸エステル塩(POE−オレイルエーテルリン酸ナトリウム、POE−ステアリルエーテルリン酸等);スルホコハク酸塩(例えば、ジ−2−エチルヘキシルスルホコハク酸ナトリウム、モノラウロイルモノエタノールアミドポリオキシエチレンスルホコハク酸ナトリウム、ラウリルポリプロピレングリコールスルホコハク酸ナトリウム等);アルキルベンゼンスルホン酸塩(例えば、リニアドデシルベンゼンスルホン酸ナトリウム、リニアドデシルベンゼンスルホン酸トリエタノールアミン、リニアドデシルベンゼンスルホン酸等);高級脂肪酸エステル硫酸エステル塩(例えば、硬化ヤシ油脂肪酸グリセリン硫酸ナトリウム等);N−アシルグルタミン酸塩(例えば、N−ラウロイルグルタミン酸モノナトリウム、N−ステアロイルグルタミン酸ジナトリウム、N−ミリストイル−L−グルタミン酸モノナトリウム等);POE−アルキルエーテルカルボン酸;POE−アルキルアリルエーテルカルボン酸塩;α−オレフィンスルホン酸塩;高級脂肪酸エステルスルホン酸塩;二級アルコール硫酸エステル塩;高級脂肪酸アルキロールアミド硫酸エステル塩;ラウロイルモノエタノールアミドコハク酸ナトリウム;N−パルミトイルアスパラギン酸ジトリエタノールアミン;カゼインナトリウム等が挙げられる。 Examples of the anionic surfactant used in the present invention include those generally used in external compositions such as cosmetics, pharmaceuticals, and quasi drugs. For example, fatty acid soap (eg, sodium laurate, sodium palmitate, etc.); higher alkyl sulfates (eg, sodium lauryl sulfate, potassium lauryl sulfate); alkyl ether sulfates (eg, POE-lauryl sulfate triethanolamine) , POE-sodium lauryl sulfate, etc.); N-acyl sarcosine acid (eg, sodium lauroyl sarcosine, etc.); Phosphoric acid ester salt (POE-oleyl ether sodium phosphate, POE-stearyl ether phosphoric acid, etc.); sulfosuccinate (eg, di-2-ethylhexyl sulfate) Sodium succinate, monolauroyl monoethanolamide polyoxyethylene sodium sulfosuccinate, sodium lauryl polypropylene glycol sulfosuccinate, etc.); alkylbenzene sulfonates (eg, sodium lineardodecylbenzenesulfonate, triethanolamine lineardodecylbenzenesulfonate, lineardodecyl) Higher fatty acid ester sulfate (for example, hydrogenated coconut oil fatty acid sodium glyceryl sulfate); N-acyl glutamate (for example, monosodium N-lauroyl glutamate, disodium N-stearoyl glutamate, N-myristoyl) -L-glutamic acid monosodium etc.); POE-alkyl ether carboxylic acid; POE-alkyl allyl ether cal Α-olefin sulfonates; higher fatty acid ester sulfonates; secondary alcohol sulfates; higher fatty acid alkylolamide sulfates; lauroyl monoethanolamide sodium succinate; N-palmitoyl aspartate ditriethanolamine ; Sodium caseinate and the like.
好ましいアニオン性界面活性剤の一例として、下記一般式(I)で表される長鎖アシルスルホン酸塩型アニオン性界面活性剤が挙げられる。
R1CO−a−(CH2)nSO3M1 (I)
As an example of a preferable anionic surfactant, a long-chain acyl sulfonate type anionic surfactant represented by the following general formula (I) may be mentioned.
R 1 CO-a- (CH 2 ) n SO 3 M 1 (I)
一般式(I)中、R1CO−は炭素原子数10〜22の飽和または不飽和の脂肪族アシル基を表す。R1COとして、C11H23CO、C12H25CO、C13H27CO、C14H29CO、C15H31CO、C16H33CO、C17H35CO、ココヤシ脂肪酸残基、パームヤシ脂肪酸残基等が例示される(脂肪酸残基は脂肪酸のカルボキシル基からOH基を除いた基を意味する)。なお、R1COは、安全性等の点から、その炭素原子数が12〜22のものがより好ましい。 In the general formula (I), R 1 CO— represents a saturated or unsaturated aliphatic acyl group having 10 to 22 carbon atoms. As R 1 CO, C 11 H 23 CO, C 12 H 25 CO, C 13 H 27 CO, C 14 H 29 CO, C 15 H 31 CO, C 16 H 33 CO, C 17 H 35 CO, coconut fatty acid residue Group, palm coconut fatty acid residue and the like are exemplified (fatty acid residue means a group obtained by removing OH group from carboxyl group of fatty acid). R 1 CO is more preferably one having 12 to 22 carbon atoms from the viewpoint of safety or the like.
aは−O−または−NR−(ただし、Rは水素原子、または炭素原子数1〜3のアルキル基を示す)を表す。これらは電子供与性基である。aとしては、−O−、−NH−、−N(CH3)−が好ましい。 a represents -O- or -NR- (wherein R represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms). These are electron donating groups. a is preferably —O—, —NH—, or —N (CH 3 ) —.
M1はアルカリ金属類、アルカリ土類金属類、アンモニウムまたは有機アミン類を表す。M1として、例えばリチウム、カリウム、ナトリウム、カルシウム、マグネシウム、アンモニウム、モノエタノールアミン、ジエタノールアミン、トリエタノールアミン、タウリンナトリウム、N−メチルタウリンナトリウム等が挙げられる。
nは1〜3の整数を表す。
M 1 represents an alkali metal, an alkaline earth metal, ammonium or an organic amine. Examples of M 1 include lithium, potassium, sodium, calcium, magnesium, ammonium, monoethanolamine, diethanolamine, triethanolamine, sodium taurine, sodium N-methyltaurine, and the like.
n represents an integer of 1 to 3.
上記一般式(I)中、aが−O−を示す化合物、すなわち長鎖アシルイセチオン酸塩型アニオン性界面活性剤としては、ココイルイセチオン酸塩、ステアロイルイセチオン酸塩、ラウリルイセチオン酸塩、ミリストイルイセチオン酸塩等が例示される。 In the general formula (I), a compound in which a represents —O—, that is, a long-chain acyl isethionate type anionic surfactant includes cocoyl isethionate, stearoyl isethionate, lauryl isethionate, Examples include myristoyl isethionate.
上記一般式(I)中、aが−NH−を示す化合物、すなわち長鎖アシルタウリン塩型アニオン性界面活性剤としては、N−ラウロイルタウリン塩、N−ココイル−N−エタノールタウリン塩、N−ミリストイルタウリン塩、N−ステアロイルタウリン塩等が例示される。 In the above general formula (I), a compound in which a represents —NH—, that is, a long-chain acyl taurine salt type anionic surfactant includes N-lauroyl taurine salt, N-cocoyl-N-ethanol taurine salt, N— Examples include myristoyl taurine salt and N-stearoyl taurine salt.
上記一般式(I)中、aが−N(CH3)−を示す化合物、すなわち長鎖アシルメチルタウリン塩型アニオン性界面活性剤としては、N−ラウロイル−N−メチルタウリン塩、N−パルミトイル−N−メチルタウリン塩、N−ステアロイル−N−メチルタウリン塩、N−ココイル−N−メチルタウリン塩等が例示される。 In the above general formula (I), a compound in which a represents —N (CH 3 ) —, that is, a long-chain acylmethyl taurate salt type anionic surfactant includes N-lauroyl-N-methyl taurate, N-palmitoyl -N-methyl taurine salt, N-stearoyl-N-methyl taurine salt, N-cocoyl-N-methyl taurine salt and the like are exemplified.
これらのうち、好ましくは長鎖アシルメチルタウリン塩型アニオン性界面活性剤であり、特に好ましいものは、N−ステアロイル−N−メチルタウリンナトリウムなどのN−ステアロイル−N−メチルタウリン塩である。 Of these, long-chain acylmethyl taurate salt type anionic surfactants are preferred, and particularly preferred are N-stearoyl-N-methyl taurine salts such as sodium N-stearoyl-N-methyl taurate.
また、別の好ましいアニオン性界面活性剤の例として、下記一般式(II)で示される長鎖アシルグルタミン酸塩型アニオン性界面活性剤も挙げられる。
R2CO−NH−CH(COOM2)−CH2CH2−COOM2 (II)
Moreover, as an example of another preferable anionic surfactant, a long-chain acylglutamate type anionic surfactant represented by the following general formula (II) may also be mentioned.
R 2 CO-NH-CH ( COOM 2) -CH 2 CH 2 -COOM 2 (II)
R2CO−は炭素原子数16〜22の飽和または不飽和の脂肪族アシル基を表す。M2はアルカリ金属類、アルカリ土類金属類、アンモニウムまたは有機アミン類を表す。M1として、例えばリチウム、カリウム、ナトリウム、カルシウム、マグネシウム、アンモニウム、モノエタノールアミン、ジエタノールアミン、トリエタノールアミン、タウリンナトリウム、N−メチルタウリンナトリウム等が挙げられる。
代表例としては、例えば、N−ステアロイル−L−グルタミン酸ナトリウム、N−パルミトイル−L−グルタミン酸ナトリウム、N−ステアロイルグルタミン酸−L−トリエタノールアミンなどが挙げられる。
R 2 CO— represents a saturated or unsaturated aliphatic acyl group having 16 to 22 carbon atoms. M 2 represents an alkali metal, an alkaline earth metal, ammonium or an organic amine. Examples of M 1 include lithium, potassium, sodium, calcium, magnesium, ammonium, monoethanolamine, diethanolamine, triethanolamine, sodium taurine, sodium N-methyltaurine, and the like.
Representative examples include, for example, sodium N-stearoyl-L-glutamate, sodium N-palmitoyl-L-glutamate, and N-stearoyl glutamic acid-L-triethanolamine.
本発明において、アニオン性界面活性剤は、O/W乳化組成物全量中0.01〜5質量%、好ましくは0.02〜3質量%である。アニオン性界面活性剤は1種または2種以上を併用して用いることも可能である。 In the present invention, the anionic surfactant is 0.01 to 5% by mass, preferably 0.02 to 3% by mass, based on the total amount of the O / W emulsion composition. Anionic surfactants can be used alone or in combination of two or more.
本発明で得られるO/W乳化組成物の乳化粒子界面においては、(A)高級脂肪族アルコールと(C)アニオン性界面活性剤とが、ラメラ状の2分子膜からなる会合体を形成し、いわゆるα−ゲルの状態をとっている。 At the emulsified particle interface of the O / W emulsified composition obtained in the present invention, (A) a higher aliphatic alcohol and (C) an anionic surfactant form an aggregate consisting of a lamellar bimolecular film. The so-called α-gel state is taken.
α−ゲルはO/W乳化組成物の安定化に寄与することから、(A)高級脂肪族アルコールと(C)アニオン性界面活性剤との合計量は、O/W乳化組成物中、(B)油分10質量部に対して0.5〜10質量部とすることが好ましい。0.5質量部未満の場合には、α−ゲル量が少ないため、得られたO/W乳化組成物の安定性が不十分となる場合がある。また、10質量部を超える場合には、α−ゲルが多すぎるため使用感の点で好ましくない傾向がある。 Since α-gel contributes to the stabilization of the O / W emulsion composition, the total amount of (A) higher aliphatic alcohol and (C) anionic surfactant is ( B) It is preferable to set it as 0.5-10 mass parts with respect to 10 mass parts of oil components. When the amount is less than 0.5 parts by mass, the amount of α-gel is small, and thus the stability of the obtained O / W emulsion composition may be insufficient. Moreover, when it exceeds 10 mass parts, since there is too much (alpha) -gel, there exists a tendency which is not preferable at the point of a usability | use_condition.
また、前記のように、α−ゲルはDSC測定で吸熱ピークを示すが、吸熱ピーク温度はα−ゲルの融点と考えることができる。α−ゲルは、融点以上の温度では低粘度化が起こるため、O/W乳化組成物の高温安定性に影響を及ぼす可能性がある。
よって、O/W乳化組成物の高温安定性の点からは、α−ゲルの融点が高い方がよく、60℃以上、さらには65℃以上であるのが好ましい。
As described above, α-gel exhibits an endothermic peak by DSC measurement, and the endothermic peak temperature can be considered as the melting point of α-gel. Since the α-gel is reduced in viscosity at a temperature equal to or higher than the melting point, it may affect the high temperature stability of the O / W emulsion composition.
Therefore, from the viewpoint of high temperature stability of the O / W emulsion composition, the melting point of the α-gel is preferably high, and is preferably 60 ° C. or higher, and more preferably 65 ° C. or higher.
<(D)アルキレンオキシド誘導体>
(D)成分のアルキレンオキシド誘導体としては、例えば、下記一般式(1)で示されるものが挙げられる。
<(D) Alkylene oxide derivative>
(D) As an alkylene oxide derivative of a component, what is shown by following General formula (1) is mentioned, for example.
R1O−[(AO)m(EO)n]−R2 (1) R 1 O - [(AO) m (EO) n] -R 2 (1)
一般式(1)において、AOは炭素数3〜4のオキシアルキレン基であり、具体的には、オキシプロピレン基、オキシブチレン基、オキシイソブチレン基、オキシトリメチレン基、オキシテトラメチレン基などが挙げられる。好ましくは、オキシプロピレン基、オキシブチレン基が挙げられる。
本発明においては、炭素数3〜4のオキシアルキレン基とオキシエチレン基の合計中のオキシアルキレン基の比率が20〜80質量%、さらには30〜70質量%であることが好ましい。オキシアルキレン基の割合が小さすぎると微細化効果が低下し、また大きすぎると水に溶けずに使用が困難となる。
In the general formula (1), AO is an oxyalkylene group having 3 to 4 carbon atoms, and specific examples include an oxypropylene group, an oxybutylene group, an oxyisobutylene group, an oxytrimethylene group, and an oxytetramethylene group. It is done. Preferably, an oxypropylene group and an oxybutylene group are mentioned.
In this invention, it is preferable that the ratio of the oxyalkylene group in the sum total of a C3-C4 oxyalkylene group and an oxyethylene group is 20-80 mass%, Furthermore, it is preferable that it is 30-70 mass%. If the proportion of the oxyalkylene group is too small, the effect of refining is reduced, and if it is too large, it does not dissolve in water and is difficult to use.
mは炭素数3〜4のオキシアルキレン基の平均付加モル数、nはオキシエチレン基の平均付加モル数であり、それぞれ1〜70の範囲であることができ、好ましくは2〜60である。なお、mとnの合計が大きすぎるとべたつくことがあるので、(m+n)は好ましくは100以下である。 m is the average addition mole number of the oxyalkylene group having 3 to 4 carbon atoms, and n is the average addition mole number of the oxyethylene group, each of which can be in the range of 1 to 70, preferably 2 to 60. In addition, since it may become sticky when the sum of m and n is too large, (m + n) is preferably 100 or less.
エチレンオキシドおよび炭素数3〜4のアルキレンオキシドの付加する順序は特に指定はない。またオキシエチレン基と炭素数3〜4のオキシアルキレン基はブロック状に付加していてもランダム状に付加していてもよい。ブロック状には2段ブロックのみならず、3段以上のブロックも含まれる。好ましくはランダム状に付加されているものが挙げられる。 The order of adding ethylene oxide and alkylene oxide having 3 to 4 carbon atoms is not particularly specified. Further, the oxyethylene group and the oxyalkylene group having 3 to 4 carbon atoms may be added in a block shape or in a random shape. The block shape includes not only two-stage blocks but also three or more stages. Preferably, those added randomly are listed.
R1及びR2は炭素数1〜4のアルキル基で、メチル基、エチル基、n−プロピル基、イソプロピル基、n−ブチル基、sec−ブチル基、tert−ブチル基などが挙げられる。好ましくはメチル基、エチル基である。5以上の炭化水素基では親水性が低下し、水に溶けにくくなる。R1,R2は、同一であっても異なっていても良い。 R 1 and R 2 are alkyl groups having 1 to 4 carbon atoms, and examples thereof include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, a sec-butyl group, and a tert-butyl group. A methyl group and an ethyl group are preferred. When the number of hydrocarbon groups is 5 or more, the hydrophilicity is lowered and the water is hardly dissolved. R 1 and R 2 may be the same or different.
本発明のアルキレンオキシド誘導体は公知の方法で製造することができる。例えば、水酸基を有している化合物にエチレンオキシドおよび炭素数3〜4のアルキレンオキシドを付加重合した後、ハロゲン化アルキルをアルカリ触媒の存在下にエーテル反応させることによって得られる。 The alkylene oxide derivative of the present invention can be produced by a known method. For example, it can be obtained by subjecting a compound having a hydroxyl group to addition polymerization of ethylene oxide and an alkylene oxide having 3 to 4 carbon atoms, and then subjecting an alkyl halide to an ether reaction in the presence of an alkali catalyst.
一般式(1)のアルキレンオキシド誘導体の好適な例としては、例えば、POE(14)POP(7)ジメチルエーテル、POE(36)POP(41)ジメチルエーテル、POE(55)POP(28)ジメチルエーテル、POE(22)POP(40)ジメチルエーテル、POE(35)POP(40)ジメチルエーテル、POE(50)POP(40)ジメチルエーテル、POE(11)POP(9)ジメチルエーテル等が挙げられるが、これらに限定されるものではない。 Preferable examples of the alkylene oxide derivative of the general formula (1) include, for example, POE (14) POP (7) dimethyl ether, POE (36) POP (41) dimethyl ether, POE (55) POP (28) dimethyl ether, POE ( 22) POP (40) dimethyl ether, POE (35) POP (40) dimethyl ether, POE (50) POP (40) dimethyl ether, POE (11) POP (9) dimethyl ether, etc., but are not limited thereto. Absent.
本発明においては、乳化パーツ中に(D)アルキレンオキシド誘導体を1〜30質量%、好ましくは3〜25質量%配合する。
(D)アルキレンオキシド誘導体は、乳化パーツ中1〜30質量%である限り、第2水相中にも配合することができる。よって、本発明で得られるO/W乳化組成物中のアルキレンオキシド誘導体量はほとんど制限されない。
In this invention, 1-30 mass%, Preferably 3-25 mass% of (D) alkylene oxide derivatives are mix | blended in an emulsification part.
(D) As long as it is 1-30 mass% in an emulsion part, an alkylene oxide derivative can be mix | blended also in a 2nd aqueous phase. Therefore, the amount of the alkylene oxide derivative in the O / W emulsion composition obtained in the present invention is hardly limited.
<(E)水>
本発明において、水は少なくとも乳化パーツ調製に用いる第1水相に含まれる。第1水相中に含まれる水は乳化パーツが調整可能な量を用いればよく、通常は乳化パーツ中55〜90質量%、好ましくは60〜85質量%である。
また、乳化パーツを冷却するための第2水相中にも含まれることが好ましい。
本発明で得られるO/W乳化組成物における水の総配合量は、特に限定されるものではないが、通常はO/W乳化組成物全量中40〜95質量%である。
<(E) Water>
In the present invention, water is contained in at least the first aqueous phase used for preparing the emulsified parts. The amount of water contained in the first aqueous phase may be adjusted so that the emulsifying part can be adjusted, and is usually 55 to 90% by mass, preferably 60 to 85% by mass in the emulsifying part.
Moreover, it is preferable that it is contained also in the 2nd water phase for cooling an emulsification part.
Although the total amount of water in the O / W emulsion composition obtained in the present invention is not particularly limited, it is usually 40 to 95% by mass in the total amount of the O / W emulsion composition.
第1水相は、O/W乳化組成物全量中の25〜50質量%が好ましく、30〜45質量%がより好ましい。第1水相が少なすぎると安定なO/W乳化組成物が得られないことがあり、第1水相が多すぎると乳化パーツを冷却する第2水相が少なくなるために、経済性に劣る。
また、第2水相は、O/W乳化組成物全量中40〜75質量%が好ましく、45〜70質量%がより好ましい。第2水相が、40質量%未満であると十分な冷却効果が得られず、その分余計な冷却エネルギーを必要とするため、経済性に劣る。また、75質量%を超えるとO/W乳化パーツを調製する第1水相が少なくなるために、安定なO/W乳化組成物の調製が困難になる傾向にある。
The first aqueous phase is preferably from 25 to 50 mass%, more preferably from 30 to 45 mass%, based on the total amount of the O / W emulsion composition. If the first aqueous phase is too small, a stable O / W emulsified composition may not be obtained, and if the first aqueous phase is too much, the second aqueous phase for cooling the emulsified parts will be reduced. Inferior.
Moreover, 40-75 mass% is preferable in a 2nd aqueous phase with respect to O / W emulsion composition whole quantity, and 45-70 mass% is more preferable. If the second aqueous phase is less than 40% by mass, a sufficient cooling effect cannot be obtained, and an extra amount of cooling energy is required. Moreover, since the 1st aqueous phase which prepares O / W emulsification parts will decrease when it exceeds 75 mass%, it exists in the tendency for preparation of a stable O / W emulsification composition to become difficult.
また、O/W乳化パーツに添加する第2水相(残部水相)の温度は10〜35℃が好ましく、15〜30℃であることが特に好ましい。10℃未満であると、第2水相を冷やすエネルギーが過剰に必要となり、経済性に劣る傾向にある。また、35℃を超えると、十分な冷却効果が得られず、その分余計な冷却エネルギーを必要とするため、経済性に劣る。 Moreover, 10-35 degreeC is preferable and, as for the temperature of the 2nd water phase (remaining water phase) added to O / W emulsification parts, it is especially preferable that it is 15-30 degreeC. If it is less than 10 ° C., excessive energy for cooling the second aqueous phase is required, and the economy tends to be inferior. Moreover, when it exceeds 35 degreeC, since sufficient cooling effect is not acquired and extra cooling energy is needed by that much, it is inferior to economical efficiency.
<その他成分>
本発明にかかるO/W乳化組成物には、上記必須成分の他に、通常、化粧品、医薬品等に用いられる成分を本発明の効果を損なわない範囲で配合することができる。かかる成分としては、例えば次のようなものが挙げられるが、これらに限定されるものではない。
<Other ingredients>
In the O / W emulsion composition according to the present invention, in addition to the above essential components, components usually used in cosmetics, pharmaceuticals and the like can be blended within a range not impairing the effects of the present invention. Examples of such components include the following, but are not limited thereto.
1,3−ブチレングリコール、ジプロピレングリコール、イソプレングリコール、1,2−ペンタングリコール、1,2−ヘキサングリコール、2−メチル−1,3−プロパノール、エチルカルビトール、1,2−ブチレングリコール、グリセリン等の水性溶媒。 1,3-butylene glycol, dipropylene glycol, isoprene glycol, 1,2-pentane glycol, 1,2-hexane glycol, 2-methyl-1,3-propanol, ethyl carbitol, 1,2-butylene glycol, glycerin An aqueous solvent such as
ポリエチレングリコール及びそのモノ−又はジ−アルキルエーテル、ポリエチレングリコール・ポリプロピレングリコール共重合物及びそのモノ−又はジ−アルキルエーテル、ソルビトール、キシリトール、マルチトール、ムコ多糖、ヒアルロン酸、コンドロイチン硫酸、キトサンなどの保湿剤。 Moisturizing of polyethylene glycol and its mono- or di-alkyl ether, polyethylene glycol / polypropylene glycol copolymer and its mono- or di-alkyl ether, sorbitol, xylitol, maltitol, mucopolysaccharide, hyaluronic acid, chondroitin sulfate, chitosan, etc. Agent.
メチルセルロース、エチルセルロース、アラビアガム、ポリビニルアルコールなどの増粘剤。
エタノールなどの有機溶剤。
ブチルヒドロキシトルエン、トコフェロール、フィチン酸などの酸化防止剤。
安息香酸、サリチル酸、ソルビン酸、パラオキシ安息香酸エステル(エチルパラベン、ブチルパラベンなど)、ヘキサクロロフェンなどの抗菌防腐剤。
Thickeners such as methylcellulose, ethylcellulose, gum arabic, and polyvinyl alcohol.
Organic solvents such as ethanol.
Antioxidants such as butylhydroxytoluene, tocopherol and phytic acid.
Antibacterial preservatives such as benzoic acid, salicylic acid, sorbic acid, paraoxybenzoic acid esters (such as ethylparaben and butylparaben), and hexachlorophene.
グリシン、アラニン、バリン、ロイシン、セリン、トレオニン、フェニルアラニン、チロシン、アスパラギン酸、アスパラギン、グルタミン、タウリン、アルギニン、ヒスチジンなどのアミノ酸とその塩。
アシルサルコシン酸(例えばラウロイルサルコシンナトリウム)、グルタチオン、クエン酸、リンゴ酸、酒石酸、乳酸などの有機酸及びその塩。
Amino acids and salts thereof such as glycine, alanine, valine, leucine, serine, threonine, phenylalanine, tyrosine, aspartic acid, asparagine, glutamine, taurine, arginine, histidine.
Organic acids such as acyl sarcosine acid (eg, lauroyl sarcosine sodium), glutathione, citric acid, malic acid, tartaric acid, lactic acid, and salts thereof.
ビタミンA及びその誘導体、ビタミンB6塩酸塩、ビタミンB6トリパルミテート、ビタミンB6ジオクタノエート、ビタミンB2及びその誘導体、ビタミンB12、ビタミンB15及びその誘導体などのビタミンB類、アスコルビン酸、アスコルビン酸リン酸エステル(塩)、アスコルビン酸ジパルミテートなどのビタミンC類、α―トコフェロール、β―トコフェロール、γ―トコフェロール、ビタミンEアセテート、ビタミンEニコチネートなどのビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチンなどのビタミン類。 Vitamin A and its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 and its derivatives, vitamin B such as vitamin B12, vitamin B15 and its derivatives, ascorbic acid, ascorbic acid phosphate ( Salt), vitamin C such as ascorbic acid dipalmitate, α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate, vitamin E nicotinate and other vitamin E, vitamin D, vitamin H, pantothenic acid, pantethine, etc. Vitamins.
ニコチン酸アミド、ニコチン酸ベンジル、γ―オリザノール、アラントイン、グリチルリチン酸(塩)、グリチルレチン酸及びその誘導体、ヒノキチオール、ムシジン、ビサボロール、ユーカリプトール、チモール、イノシトール、サポニン類(サイコサポニン、ニンジンサポニン、ヘチマサポニン、ムクロジサポニンなど)、パントテニルエチルエーテル、エチニルエストラジオール、トラネキサム酸、セファランチン、プラセンタエキスなどの各種薬剤。 Nicotinamide, benzyl nicotinate, γ-oryzanol, allantoin, glycyrrhizic acid (salt), glycyrrhetinic acid and its derivatives, hinokitiol, mucidin, bisabolol, eucalyptol, thymol, inositol, saponins (psychosaponin, carrot saponin, loofah) Various drugs such as saponin, muclodisaponin, etc.), pantothenyl ethyl ether, ethinyl estradiol, tranexamic acid, cephalanthin, placenta extract.
ギシギシ、クララ、コウホネ、オレンジ、セージ、タイム、ノコギリソウ、ゼニアオイ、センキュウ、センブリ、トウキ、トウヒ、バーチ、スギナ、ヘチマ、マロニエ、ユキノシタ、アルニカ、ユリ、ヨモギ、シャクヤク、アロエ、クチナシ、サワラなどの有機溶剤、アルコール、多価アルコール、水、水性アルコールなどで抽出した天然エキス。
ステアリルトリメチルアンモニウムクロライド、塩化ベンザルコニウム、ラウリルアミンオキサイドなどのカチオン界面活性剤。
Bark, Clara, Kouhone, Orange, Sage, Thyme, Yarrow, Zeni-Oyaku, Senkyu, Assembly, Spruce, Spruce, Birch, Horsetail, Loofah, Maronier, Yukishinoshita, Arnica, Lily, Artemisia, Peonies, Aloe, Gardenia, Sawan Natural extract extracted with solvent, alcohol, polyhydric alcohol, water, aqueous alcohol.
Cationic surfactants such as stearyltrimethylammonium chloride, benzalkonium chloride, and laurylamine oxide.
ポリオキシエチレン脂肪酸グリセリル、ポリオキシエチレン・メチルポリシロキサン共重合体、脂肪酸ポリオキシエチレンソルビタン、ポリオキシエチレンアルキルエーテル、マルチトールヒドロキシ脂肪族アルキルエーテル、アルキル化多糖、アルキルグルコシド、ショ糖脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油グリセリルなどのノニオン性界面活性剤。 Polyoxyethylene fatty acid glyceryl, polyoxyethylene methylpolysiloxane copolymer, fatty acid polyoxyethylene sorbitan, polyoxyethylene alkyl ether, maltitol hydroxy aliphatic alkyl ether, alkylated polysaccharide, alkyl glucoside, sucrose fatty acid ester, poly Nonionic surfactants such as oxyethylene hydrogenated castor oil glyceryl.
エデト酸二ナトリウム、エデト酸三ナトリウム、クエン酸ナトリウム、ポリリン酸ナトリウム、メタリン酸ナトリウム、グルコン酸等の金属封鎖剤。水酸化カリウム、水酸化ナトリウム、トリエタノールアミン等の中和剤。 Metal sequestering agents such as disodium edetate, trisodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate and gluconic acid. Neutralizing agents such as potassium hydroxide, sodium hydroxide and triethanolamine.
また、その他、香料、スクラブ剤、粉末、色材、美白剤、紫外線吸収剤や紫外線散乱剤などの紫外線防御剤なども、安定性などを損なわない範囲で適宜配合することができる。
各成分は、通常、親油性成分は油相に、親水性成分は第1水相及び/又は第2水相に配合される。
In addition, fragrances, scrub agents, powders, coloring materials, whitening agents, UV protection agents such as UV absorbers and UV scattering agents, and the like can be appropriately blended as long as stability is not impaired.
As for each component, a lipophilic component is usually blended with the oil phase, and a hydrophilic component is blended with the first aqueous phase and / or the second aqueous phase.
本発明にかかるO/W乳化組成物は、例えば、化粧料、医薬、医薬部外品において皮膚、頭髪など身体に適用し得る外用組成物などに好適に適用することができる。例えば、乳液、クリーム、マッサージクリーム、クレンジングクリーム、エッセンス、ボディクリーム等のスキンケア化粧料;ヘアクリーム、コンディショナー、リンス等のヘアケア化粧料;サンスクリーン等の日焼け止め化粧料;クレンジング、メーク落としなどの洗浄料;ファンデーション等のメーキャップ化粧料等;整髪料等の毛髪化粧料等に用いることができる。 The O / W emulsified composition according to the present invention can be suitably applied to, for example, an external composition that can be applied to the body such as skin and hair in cosmetics, medicines, and quasi drugs. For example, skin care cosmetics such as emulsions, creams, massage creams, cleansing creams, essences and body creams; hair care cosmetics such as hair creams, conditioners and rinses; sunscreen cosmetics such as sunscreens; cleansings, makeup removers, etc. It can be used for makeup cosmetics such as foundations; hair cosmetics such as hair styling.
以下、具体例を挙げて本発明について更に詳しく説明するが、本発明はこれに限定されるものではない。なお、特に断りのない限り、配合量は全て質量%で示す。
まず、本発明で用いた試験法について説明する。
Hereinafter, the present invention will be described in more detail with reference to specific examples, but the present invention is not limited thereto. Unless otherwise specified, all compounding amounts are shown in mass%.
First, the test method used in the present invention will be described.
<乳化粒子径>
調製直後のO/W乳化組成物の乳化粒子径を電子顕微鏡にて観察し、下記評価基準により評価した。
(評価基準)
○:5μmよりも大きい乳化粒子がない。
△:10μmよりも大きい乳化粒子がない。
×:10μmよりも大きい乳化粒子がある。
<Emulsified particle size>
The emulsified particle diameter of the O / W emulsified composition immediately after preparation was observed with an electron microscope and evaluated according to the following evaluation criteria.
(Evaluation criteria)
A: There are no emulsified particles larger than 5 μm.
Δ: There are no emulsified particles larger than 10 μm.
X: There are emulsified particles larger than 10 μm.
<粘度>
調製直後のO/W乳化組成物の粘度をB型粘度計(ローター番号3番、ローター回転数12rpm)を用いて30℃にて測定を行った。
<Viscosity>
The viscosity of the O / W emulsified composition immediately after the preparation was measured at 30 ° C. using a B-type viscometer (rotor number 3, rotor rotation speed 12 rpm).
試験例1
水中でα−ゲルを形成する高級脂肪族アルコールとアニオン性界面活性剤とを用い、下記表1の組成でO/W乳化組成物を調製した。製造方法は次の通りである。
Test example 1
An O / W emulsion composition having the composition shown in Table 1 below was prepared using a higher aliphatic alcohol that forms an α-gel in water and an anionic surfactant. The manufacturing method is as follows.
<試料1−2〜試料1−4(製法a)>
(1)第1水相(成分1〜6)を加熱混合し、80〜85℃で溶解させる。
(2)油相(成分7〜11)を加熱混合し、80〜85℃で溶解させる。
(3)第1水相及び油相を、ホモジナイザーで攪拌混合し、乳化パーツを調製する。
(4)乳化パーツをホモジナイザーで攪拌しながら室温(約20℃)の第2水相(成分12〜13)を乳化パーツ中に混合して、O/W乳化組成物を得る。
<Sample 1-2 to Sample 1-4 (Production Method a)>
(1) The first aqueous phase (components 1 to 6) is heated and mixed and dissolved at 80 to 85 ° C.
(2) The oil phase (components 7 to 11) is heated and mixed and dissolved at 80 to 85 ° C.
(3) The first aqueous phase and the oil phase are stirred and mixed with a homogenizer to prepare an emulsified part.
(4) While stirring the emulsified part with a homogenizer, the second aqueous phase (components 12 to 13) at room temperature (about 20 ° C.) is mixed into the emulsified part to obtain an O / W emulsion composition.
<試料1−1(製法b)>
(1)水相(成分1〜6及び成分12〜13)を加熱混合し、80〜85℃で溶解させる。
(2)油相(成分7〜11)を加熱混合し、80〜85℃で溶解させる。
(3)水相及び油相を、ホモジナイザーで攪拌混合して乳化し、オンレーターにて40℃まで冷却して、O/W乳化組成物を得た。
<Sample 1-1 (Production Method b)>
(1) The water phase (components 1 to 6 and components 12 to 13) is heated and mixed and dissolved at 80 to 85 ° C.
(2) The oil phase (components 7 to 11) is heated and mixed and dissolved at 80 to 85 ° C.
(3) The aqueous phase and the oil phase were stirred and mixed with a homogenizer, emulsified, and cooled to 40 ° C. with an on-lator to obtain an O / W emulsion composition.
試料1−1の組成は、オンレータを用いた従来法(製法b)で乳化粒子径が微細なO/W乳化組成物を得ることができる組成である。
試料1−2及び試料1−3は何れも、試料1−1と同じ組成のO/W乳化組成物を乳化パーツを第2水相で冷却する方法(製法a)で調製した場合である。
試料1−2のように乳化パーツ中に(D)アルキレンオキシド誘導体が存在していないと、例え冷却用の第2水相中に(D)アルキレンオキシド誘導体が存在していたとしても、乳化粒子径が微細なO/W乳化組成物を得ることができなかった。
The composition of Sample 1-1 is a composition capable of obtaining an O / W emulsion composition having a fine emulsion particle diameter by a conventional method (production method b) using an onlator.
Both Sample 1-2 and Sample 1-3 are cases where an O / W emulsion composition having the same composition as Sample 1-1 was prepared by a method of cooling the emulsified part in the second aqueous phase (Production Method a).
If (D) alkylene oxide derivative is not present in the emulsified part as in Sample 1-2, even if (D) alkylene oxide derivative is present in the second aqueous phase for cooling, the emulsified particles An O / W emulsion composition having a fine diameter could not be obtained.
これに対して、試料1−3のように、乳化パーツ中に(D)アルキレンオキシド誘導体が存在する場合には、試料1−1と同様に乳化粒子径が微細なO/W乳化組成物を得ることができた。また、粘度についても、試料1−1と同程度のO/W乳化組成物を得ることができた。
また、試料1−4のように、α−ゲルを形成するアニオン性界面活性剤が異なる場合でも、乳化パーツ中に(D)アルキレンオキシド誘導体が存在する場合には、試料1−3と同様に乳化粒子径が微細なO/W乳化組成物を得ることができた。
On the other hand, when (D) an alkylene oxide derivative is present in the emulsified part as in Sample 1-3, an O / W emulsion composition having a fine emulsified particle diameter is obtained as in Sample 1-1. I was able to get it. Moreover, about the viscosity, the O / W emulsion composition comparable as the sample 1-1 was able to be obtained.
In addition, even when the anionic surfactant forming the α-gel is different as in Sample 1-4, when (D) an alkylene oxide derivative is present in the emulsified part, as in Sample 1-3. An O / W emulsion composition having a fine emulsion particle size could be obtained.
試験例2
表1の試料1−3において、乳化パーツ中の(D)アルキレンオキシド誘導体濃度を変えて検討を行なった。O/W乳化組成物の製造は製法aに準じて行った。
Test example 2
In Sample 1-3 of Table 1, the (D) alkylene oxide derivative concentration in the emulsified part was changed and examined. The O / W emulsion composition was produced according to the production method a.
表2のように、乳化パーツ中の(D)アルキレンオキシド誘導体の濃度が少なすぎても多すぎても乳化粒子径が粗大化する傾向がある。また、オンレータ等を用いる従来法で調製された同じ組成のO/W乳化組成物に比べて粘度が低下してしまう。
このようなことから、乳化パーツ中の(D)アルキレンオキシド誘導体の濃度が1〜30質量%、さらには3〜25質量%であることが好適であると考えられた。
As shown in Table 2, the emulsified particle diameter tends to be coarse even if the concentration of the (D) alkylene oxide derivative in the emulsified part is too small or too large. Moreover, a viscosity will fall compared with the O / W emulsion composition of the same composition prepared by the conventional method using an onrator etc.
From such a thing, it was thought that it was suitable that the density | concentration of the (D) alkylene oxide derivative in an emulsified part is 1-30 mass%, Furthermore, it is 3-25 mass%.
試験例3
下記表3の組成で製法aに準じてO/W乳化組成物を調製した。
Test example 3
An O / W emulsion composition having the composition shown in Table 3 was prepared according to production method a.
試料3−1〜3−3からわかるように、乳化パーツ中、(D)アルキレンオキシド誘導体の代わりに他の水性溶媒やグリコール類を用いても、乳化粒子径が微細なO/W乳化組成物は得ることができない。
また、試料3−4及び試料3−5は、水中でα−ゲルを形成するアニオン性界面活性剤と高級脂肪族アルコールを用いたO/W乳化組成物において、粘度安定化効果があることが知られている塩類やカチオン性界面活性剤を乳化パーツ中に配合した場合であるが、これら成分を用いても乳化粒子径を微細化することはできない。
従って、高濃度の乳化パーツを調製してこれに低温の残部水相を混合する方法(製法a)におけるO/W乳化組成物の乳化粒子径の微細化効果は、(D)アルキレンオキシド誘導体に特異的であることが理解される。
As can be seen from Samples 3-1 to 3-3, in the emulsified part, (D) O / W emulsified composition having a fine emulsified particle diameter even when other aqueous solvent or glycol is used instead of alkylene oxide derivative. Can't get.
In addition, Sample 3-4 and Sample 3-5 may have a viscosity stabilizing effect in an O / W emulsion composition using an anionic surfactant that forms an α-gel in water and a higher aliphatic alcohol. This is the case where known salts and cationic surfactants are blended in the emulsified part, but even if these components are used, the particle size of the emulsified particles cannot be reduced.
Therefore, the effect of refining the emulsified particle size of the O / W emulsion composition in the method of preparing a high-concentration emulsified part and mixing the low-temperature remaining aqueous phase thereto (Production Method a) is as follows: It is understood to be specific.
試験例4
さらに、(D)アルキレンオキシド誘導体を変えて検討を行なった。O/W乳化組成物の製造は製法aに準じて行った。
Test example 4
Furthermore, (D) The alkylene oxide derivative was changed and examined. The O / W emulsion composition was produced according to the production method a.
表4のように、一般式(1)で示されるアルキレンオキシド誘導体であれば微細化効果が得られたが、オキシエチレン基とオキシアルキレン基の合計に占めるオキシアルキレン基の比率が小さくなると微細化効果が低下する傾向があった。また、前記比率が大きくなると、アルキレンオキシド誘導体が水に溶けにくくなり使用が困難となった。
このようなことから、オキシエチレン基とオキシアルキレン基の合計に占めるオキシアルキレン基の比率は20〜80質量%、さらには30〜70質量%であることが好ましいと考えられた。
As shown in Table 4, when the alkylene oxide derivative represented by the general formula (1) was used, the effect of miniaturization was obtained. However, when the ratio of the oxyalkylene group in the total of the oxyethylene group and the oxyalkylene group was reduced, the refinement was achieved. The effect tended to decrease. Moreover, when the said ratio became large, the alkylene oxide derivative became difficult to melt | dissolve in water and it became difficult to use it.
From this, it was considered that the ratio of the oxyalkylene group to the total of the oxyethylene group and the oxyalkylene group was preferably 20 to 80% by mass, and more preferably 30 to 70% by mass.
試験例5
下記表5の処方を用いて、製法aに準じてO/W乳化組成物を製造した。何れの場合にも、乳化粒子径が5μm以下の微細なO/W乳化組成物を得ることができた。
Test Example 5
The O / W emulsion composition was manufactured according to the manufacturing method a using the prescription of the following Table 5. In any case, a fine O / W emulsion composition having an emulsified particle size of 5 μm or less could be obtained.
実施例1 乳液
<第2水相>
1.精製水 to 100 質量%
2.ジプロピレングリコール 7.0
3.キサンタンガム 0.1
<第1水相>
4.精製水 42.0
5.EDTA−2Na・2H2O 0.1
6.クエン酸 0.01
7.クエン酸ナトリウム 0.09
8.N−ステアロイル−N−メチルタウリンナトリウム 0.2
9.POE(14)POP(7)ジメチルエーテル(ランダム) 3.0
<油相>
10.塩化ジステアリルジメチルアンモニウム 0.07
11.ステアリルアルコール 0.3
12.ベヘニルアルコール 1.1
13.テトラエチルヘキサン酸ペンタエリスリチル 1.0
14.ジメチコン 3.0
15.水添ポリデセン 1.0
Example 1 Emulsion <second aqueous phase>
1. Purified water to 100 mass%
2. Dipropylene glycol 7.0
3. Xanthan gum 0.1
<First water phase>
4). Purified water 42.0
5. EDTA-2Na · 2H 2 O 0.1
6). Citric acid 0.01
7). Sodium citrate 0.09
8). N-stearoyl-N-methyltaurine sodium 0.2
9. POE (14) POP (7) Dimethyl ether (random) 3.0
<Oil phase>
10. Distearyldimethylammonium chloride 0.07
11. Stearyl alcohol 0.3
12 Behenyl alcohol 1.1
13. Pentaerythrityl tetraethylhexanoate 1.0
14 Dimethicone 3.0
15. Hydrogenated polydecene 1.0
<製造方法>
(1)第2水相(成分1〜3)を室温下で混合し、溶解させる。
(2)第1水相(成分4〜9)を80〜85℃で溶解させる。
(3)油相(成分10〜15)を80〜85℃で溶解させる。
(4)第1水相及び油相をホモジナイザーで攪拌混合して、乳化パーツを調製する。
(5)乳化パーツをホモジナイザーで攪拌しながら第2水相を添加して混合し、O/W乳液を得る。
<Manufacturing method>
(1) The second aqueous phase (components 1 to 3) is mixed and dissolved at room temperature.
(2) The first aqueous phase (components 4 to 9) is dissolved at 80 to 85 ° C.
(3) The oil phase (components 10 to 15) is dissolved at 80 to 85 ° C.
(4) The first aqueous phase and the oil phase are stirred and mixed with a homogenizer to prepare an emulsified part.
(5) The second aqueous phase is added and mixed while stirring the emulsified part with a homogenizer to obtain an O / W emulsion.
実施例1において、乳化パーツ(成分4〜15)中の成分9の濃度は5.8質量%、得られた乳液の粘度は3,770mPa・s/30℃、乳化粒子径は1〜5μmの範囲であった。 In Example 1, the concentration of component 9 in the emulsified parts (components 4 to 15) is 5.8% by mass, the viscosity of the obtained emulsion is 3,770 mPa · s / 30 ° C., and the emulsified particle size is 1 to 5 μm. It was in range.
実施例2 乳液
<第2水相>
1.精製水 to 100 質量%
2.キシリトール 1.0
3.ジプロピレングリコール 3.0
4.グリセリン 5.0
5.ブチレングリコール 3.0
6.キサンタンガム 0.1
7.グリチルリチン酸ジカリウム 0.05
8.エタノール 4.0
9.フェノキシエタノール 0.5
<第1水相>
10.精製水 30.0
11.EDTA−2Na・2H2O 0.1
12.クエン酸 0.01
13.クエン酸ナトリウム 0.09
14.N−ステアロイル−N−メチルタウリンナトリウム 0.2
15.POE(14)POP(7)ジメチルエーテル(ランダム) 1.0
<油相>
16.ステアリルアルコール 0.3
17.ベヘニルアルコール 1.1
18.テトラエチルヘキサン酸ペンタエリスリチル 1.0
19.ジメチコン 3.0
20.水添ポリデセン 1.0
21.酢酸トコフェロール 0.05
Example 2 Emulsion <second aqueous phase>
1. Purified water to 100 mass%
2. Xylitol 1.0
3. Dipropylene glycol 3.0
4). Glycerin 5.0
5. Butylene glycol 3.0
6). Xanthan gum 0.1
7). Dipotassium glycyrrhizinate 0.05
8). Ethanol 4.0
9. Phenoxyethanol 0.5
<First water phase>
10. Purified water 30.0
11. EDTA-2Na · 2H 2 O 0.1
12 Citric acid 0.01
13. Sodium citrate 0.09
14 N-stearoyl-N-methyltaurine sodium 0.2
15. POE (14) POP (7) Dimethyl ether (random) 1.0
<Oil phase>
16. Stearyl alcohol 0.3
17. Behenyl alcohol 1.1
18. Pentaerythrityl tetraethylhexanoate 1.0
19. Dimethicone 3.0
20. Hydrogenated polydecene 1.0
21. Tocopherol acetate 0.05
<製造方法>
(1)第2水相(成分1〜9)を室温下で混合し、溶解させる。
(2)第1水相(成分10〜15)を80〜85℃で溶解させる。
(3)油相(成分16〜21)を80〜85℃で溶解させる。
(4)第1水相及び油相をホモジナイザーで攪拌混合し、乳化パーツを調製する。
(5)乳化パーツをホモジナイザーで攪拌しながら第2水相を添加して混合し、O/W乳液を得る。
<Manufacturing method>
(1) The second aqueous phase (components 1 to 9) is mixed and dissolved at room temperature.
(2) The first aqueous phase (components 10 to 15) is dissolved at 80 to 85 ° C.
(3) The oil phase (components 16 to 21) is dissolved at 80 to 85 ° C.
(4) The first aqueous phase and the oil phase are stirred and mixed with a homogenizer to prepare an emulsified part.
(5) The second aqueous phase is added and mixed while stirring the emulsified part with a homogenizer to obtain an O / W emulsion.
実施例2において、乳化パーツ(成分10〜成分21)中の成分15の濃度は2.6質量%、得られた乳液の粘度は3,820mPa・s/30℃、乳化粒子径は1〜5μmであった。 In Example 2, the concentration of component 15 in the emulsified parts (component 10 to component 21) is 2.6% by mass, the viscosity of the obtained emulsion is 3,820 mPa · s / 30 ° C., and the emulsified particle size is 1 to 5 μm. Met.
実施例3 乳液
<第2水相>
1.精製水 to 100 質量%
2.グリセリン 7.0
3.ジプロピレングリコール 5.0
4.ブチレングリコール 5.0
5.カルボキシビニルポリマー 0.14
6.水酸化カリウム 0.07
7.エタノール 3.0
8.フェノキシエタノール 0.5
<第1水相>
9.精製水 34.0
10.EDTA−2Na・2H2O 0.01
11.N−ステアロイル−N−メチルタウリンナトリウム 0.28
12.POE(14)POP(7)ジメチルエーテル(ランダム) 3.0
<油相>
13.ステアリルアルコール 0.42
14.ベヘニルアルコール 1.54
15.ワセリン 0.2
16.パーム油 0.5
17.マカデミアナッツ油脂肪酸フィトステリル 0.1
18.テトラエチルヘキサン酸ペンタエリスリチル 4.0
19.ジイソステアリン酸グリセリル 0.6
20.水添ポリデセン 2.0
21.ジメチコン 1.0
Example 3 Latex <second aqueous phase>
1. Purified water to 100 mass%
2. Glycerin 7.0
3. Dipropylene glycol 5.0
4). Butylene glycol 5.0
5. Carboxyvinyl polymer 0.14
6). Potassium hydroxide 0.07
7). Ethanol 3.0
8). Phenoxyethanol 0.5
<First water phase>
9. Purified water 34.0
10. EDTA-2Na · 2H 2 O 0.01
11. N-stearoyl-N-methyltaurine sodium 0.28
12 POE (14) POP (7) Dimethyl ether (random) 3.0
<Oil phase>
13. Stearyl alcohol 0.42
14 Behenyl alcohol 1.54
15. Vaseline 0.2
16. Palm oil 0.5
17. Macadamia nut oil fatty acid phytosteryl 0.1
18. Pentaerythrityl tetraethylhexanoate 4.0
19. Glyceryl diisostearate 0.6
20. Hydrogenated polydecene 2.0
21. Dimethicone 1.0
<製造方法>
(1)第2水相(成分1〜8)を室温下で混合し、溶解させる。
(2)第1水相(成分9〜12)を80〜85℃で溶解させる。
(3)油相(成分13〜21)を80〜85℃で溶解させる。
(4)第1水相及び油相をホモジナイザーで攪拌混合して、乳化パーツを調製する。
(5)乳化パーツをホモジナイザーで攪拌しながら第2水相を添加して混合し、O/W乳液を得る。
<Manufacturing method>
(1) The second aqueous phase (components 1 to 8) is mixed and dissolved at room temperature.
(2) The first aqueous phase (components 9 to 12) is dissolved at 80 to 85 ° C.
(3) The oil phase (components 13 to 21) is dissolved at 80 to 85 ° C.
(4) The first aqueous phase and the oil phase are stirred and mixed with a homogenizer to prepare an emulsified part.
(5) The second aqueous phase is added and mixed while stirring the emulsified part with a homogenizer to obtain an O / W emulsion.
実施例3において、乳化パーツ(成分9〜21)中の成分12の濃度は6.3質量%、得られた乳液の粘度は5,130mPa・s/30℃、乳化粒子径は1〜5μmの範囲であった。 In Example 3, the concentration of component 12 in the emulsified part (components 9 to 21) is 6.3% by mass, the viscosity of the obtained emulsion is 5,130 mPa · s / 30 ° C., and the emulsion particle size is 1 to 5 μm. It was in range.
実施例4 乳液
<第2水相>
1.精製水 to 100 質量%
2.グリセリン 5.0
3.ブチレングリコール 7.0
4.ポリエチレングリコール1500 1.0
5.エタノール 5.0
6.フェノキシエタノール 0.5
7.クエン酸 0.02
8.クエン酸ナトリウム 0.18
9.アスコルビン酸グルコシド 1.0
<第1水相>
10.精製水 35.0
11.サクシノグルカン 0.07
12.メタリン酸ナトリウム 0.03
13.N−ステアロイル−N−メチルタウリンナトリウム 0.2
14.POE(14)POP(7)ジメチルエーテル(ランダム) 2.0
<油相>
15.セチルアルコール 0.3
16.ステアリルアルコール 1.0
17.モノステアリン酸グリセリル 0.45
18.モノステアリン酸ポリオキシエチレンソルビタン 0.6
19.水添ポリデセン 2.0
20.ジメチコン 3.0
21.メチルフェニルポリシロキサン 1.0
Example 4 Latex <second aqueous phase>
1. Purified water to 100 mass%
2. Glycerin 5.0
3. Butylene glycol 7.0
4). Polyethylene glycol 1500 1.0
5. Ethanol 5.0
6). Phenoxyethanol 0.5
7). Citric acid 0.02
8). Sodium citrate 0.18
9. Ascorbic acid glucoside 1.0
<First water phase>
10. Purified water 35.0
11. Succinoglucan 0.07
12 Sodium metaphosphate 0.03
13. N-stearoyl-N-methyltaurine sodium 0.2
14 POE (14) POP (7) Dimethyl ether (random) 2.0
<Oil phase>
15. Cetyl alcohol 0.3
16. Stearyl alcohol 1.0
17. Glyceryl monostearate 0.45
18. Polyoxyethylene sorbitan monostearate 0.6
19. Hydrogenated polydecene 2.0
20. Dimethicone 3.0
21. Methylphenylpolysiloxane 1.0
<製造方法>
(1)第2水相(成分1〜9)を室温下で混合し、溶解させる。
(2)第1水相(成分10〜14)を80〜85℃で溶解させる。
(3)油相(成分15〜21)を80〜85℃で溶解させる。
(4)第1水相及び油相をホモジナイザーで攪拌混合して、乳化パーツを調製する。
(5)乳化パーツをホモジナイザーで攪拌しながら第2水相を添加して混合し、O/W乳液を得る。
<Manufacturing method>
(1) The second aqueous phase (components 1 to 9) is mixed and dissolved at room temperature.
(2) The first aqueous phase (components 10 to 14) is dissolved at 80 to 85 ° C.
(3) The oil phase (components 15 to 21) is dissolved at 80 to 85 ° C.
(4) The first aqueous phase and the oil phase are stirred and mixed with a homogenizer to prepare an emulsified part.
(5) The second aqueous phase is added and mixed while stirring the emulsified part with a homogenizer to obtain an O / W emulsion.
実施例4において、乳化パーツ(成分10〜21)中の成分14の濃度は4.4質量%、得られた乳液の粘度は4,470mPa・s/30℃、乳化粒子径は1〜5μmの範囲であった。 In Example 4, the concentration of component 14 in the emulsified part (components 10 to 21) is 4.4 mass%, the viscosity of the obtained emulsion is 4,470 mPa · s / 30 ° C., and the emulsified particle diameter is 1 to 5 μm. It was in range.
Claims (2)
(B)油分と、
(C)前記(A)と水中でα−ゲルを形成し得るアニオン性界面活性剤と、
(D)下記一般式(1)で示されるアルキレンオキシド誘導体と、
(E)水と、
を含むO/W乳化組成物の製造方法であって、
(A)炭素数12〜26の高級脂肪族アルコールはO/W乳化組成物中0.05〜10質量%であり、
(B)油分は、炭化水素油、エステル油、シリコーン油から選ばれる1種以上を含有し、且つO/W乳化組成物中0.1〜20質量%であり、
(C)前記(A)と水中でα−ゲルを形成し得るアニオン性界面活性剤は、N−アシルスルホン酸塩型アニオン性界面活性剤及びN−アシルグルタミン酸塩型アニオン性界面活性剤から選ばれる1種以上で、且つO/W乳化組成物中0.01〜5質量%であり、
(A)炭素数12〜26の高級脂肪族アルコールと(C)アニオン性界面活性剤との合計量が、(B)油分10質量部に対して0.5〜10質量部であり、
(A)炭素数12〜26の高級脂肪族アルコールと、
(B)油分と、
を含む油相と、
(C)前記(A)と水中でα−ゲルを形成し得るアニオン性界面活性剤と、
(D)下記一般式(1)で示されるアルキレンオキシド誘導体と、
(E)水の一部と、
を含む第1水相とを、80℃以上の温度で乳化してO/W乳化パーツを調製する工程と、
前記乳化パーツを10〜35℃の残りの(E)水を含む第2水相と攪拌しながら混合することにより冷却する工程と、を含み、
前記(D)アルキレンオキシド誘導体が前記乳化パーツ中1〜30質量%であることを特徴とするO/W乳化組成物の製造方法。
R1O−[(AO)m(EO)n]−R2 (1)
(式中、AOは炭素数3〜4のオキシアルキレン基、EOはオキシエチレン基、mおよびnはそれぞれ前記オキシアルキレン基、オキシエチレン基の平均付加モル数で、1≦m≦70、1≦n≦70である。炭素数3〜4のオキシアルキレン基とオキシエチレン基の合計に対するオキシアルキレン基の割合は、20〜80重量%である。炭素数3〜4のオキシアルキレン基とオキシエチレン基はランダム状に付加している。R1,R2は、同一もしくは異なってもよい炭素数1〜4のアルキル基である。) (A) a higher aliphatic alcohol having 12 to 26 carbon atoms;
(B) oil and
(C) an anionic surfactant capable of forming an α-gel in water with the (A),
(D) an alkylene oxide derivative represented by the following general formula (1);
(E) water and
A method for producing an O / W emulsion composition comprising
(A) The higher aliphatic alcohol having 12 to 26 carbon atoms is 0.05 to 10% by mass in the O / W emulsion composition,
(B) Oil content contains 1 or more types chosen from hydrocarbon oil, ester oil, and silicone oil, and is 0.1-20 mass% in O / W emulsion composition,
(C) The anionic surfactant capable of forming an α-gel in water with (A) is selected from N-acyl sulfonate type anionic surfactants and N-acyl glutamate type anionic surfactants. One or more selected from 0.01 to 5% by mass in the O / W emulsion composition,
(A) The total amount of the higher aliphatic alcohol having 12 to 26 carbon atoms and (C) the anionic surfactant is 0.5 to 10 parts by mass with respect to 10 parts by mass of (B) oil,
(A) a higher aliphatic alcohol having 12 to 26 carbon atoms;
(B) oil and
An oil phase containing,
(C) an anionic surfactant capable of forming an α-gel in water with the (A),
(D) an alkylene oxide derivative represented by the following general formula (1);
(E) a part of water,
A step of preparing an O / W emulsified part by emulsifying a first aqueous phase containing
Cooling the emulsified part by mixing with stirring the second aqueous phase containing the remaining (E) water at 10 to 35 ° C., and
The method for producing an O / W emulsified composition, wherein the (D) alkylene oxide derivative is 1 to 30% by mass in the emulsified part.
R 1 O - [(AO) m (EO) n] -R 2 (1)
(In the formula, AO is an oxyalkylene group having 3 to 4 carbon atoms, EO is an oxyethylene group, m and n are average addition moles of the oxyalkylene group and oxyethylene group, respectively, 1 ≦ m ≦ 70, 1 ≦ n ≦ 70 The ratio of the oxyalkylene group to the total of the oxyalkylene group having 3 to 4 carbon atoms and the oxyethylene group is 20 to 80% by weight, and the oxyalkylene group and oxyethylene group having 3 to 4 carbon atoms. is .R 1, R 2, appended to the random form is the same or different and an alkyl group having 1 to 4 carbon atoms.)
The method according to claim 1 , wherein the second aqueous phase is 40 to 75% by mass in the total amount of the O / W emulsion composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012204216A JP5209816B1 (en) | 2011-10-24 | 2012-09-18 | Method for producing O / W emulsion composition |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011232643 | 2011-10-24 | ||
JP2011232643 | 2011-10-24 | ||
JP2011239954 | 2011-11-01 | ||
JP2011239954 | 2011-11-01 | ||
JP2012204216A JP5209816B1 (en) | 2011-10-24 | 2012-09-18 | Method for producing O / W emulsion composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP5209816B1 true JP5209816B1 (en) | 2013-06-12 |
JP2013116884A JP2013116884A (en) | 2013-06-13 |
Family
ID=48167550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012204216A Active JP5209816B1 (en) | 2011-10-24 | 2012-09-18 | Method for producing O / W emulsion composition |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP5209816B1 (en) |
TW (1) | TW201318642A (en) |
WO (1) | WO2013061712A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106456485A (en) * | 2014-04-21 | 2017-02-22 | 狮王株式会社 | Liquid composition for oral use and method for improving resilience to freezing thereof |
CN112272551A (en) * | 2018-06-20 | 2021-01-26 | 株式会社资生堂 | Oil-in-water emulsion composition and method for producing same |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2710297T3 (en) * | 2014-06-13 | 2019-04-24 | Shiseido Co Ltd | Intermediate alpha gel compositions, and production process for O / W emulsion cosmetic containing alpha gel using said composition |
JP6586854B2 (en) * | 2014-11-11 | 2019-10-09 | 東洋紡株式会社 | Emulsified composition |
JP2016124794A (en) * | 2014-12-26 | 2016-07-11 | ポーラ化成工業株式会社 | W/o/w emulsion composition |
JP7412068B2 (en) * | 2016-12-16 | 2024-01-12 | 株式会社 資生堂 | oil-in-water composition |
CN114788791A (en) | 2017-06-23 | 2022-07-26 | 宝洁公司 | Compositions and methods for improving the appearance of skin |
WO2019066057A1 (en) * | 2017-09-29 | 2019-04-04 | 株式会社 資生堂 | Oil-in-water emulsion cosmetic using ultramicroemulsion |
CN112165929A (en) * | 2018-06-06 | 2021-01-01 | 株式会社资生堂 | Oil-in-water type emulsion cosmetic using partially crosslinked or crosslinked dimethylpolysiloxane |
CN112437657A (en) | 2018-07-03 | 2021-03-02 | 宝洁公司 | Method of treating skin conditions |
JP6754871B2 (en) * | 2019-06-25 | 2020-09-16 | ポーラ化成工業株式会社 | W / O / W type emulsified composition |
DE102019212327A1 (en) * | 2019-08-19 | 2021-02-25 | Beiersdorf Ag | Cosmetic O / W emulsion with succinoglucan |
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
EP4157206A1 (en) | 2020-06-01 | 2023-04-05 | The Procter & Gamble Company | Method of improving penetration of a vitamin b3 compound into skin |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61153134A (en) * | 1984-12-27 | 1986-07-11 | Lion Corp | Manufacture of oil-in-water type emulsion |
JP3829048B2 (en) * | 2000-06-05 | 2006-10-04 | 株式会社資生堂 | Oil-in-water emulsion composition |
JP4731109B2 (en) * | 2003-10-31 | 2011-07-20 | 株式会社 資生堂 | Gel composition and cream composition using the same |
JP4968774B2 (en) * | 2006-08-11 | 2012-07-04 | 株式会社 資生堂 | Cream composition |
KR20120060833A (en) * | 2009-09-04 | 2012-06-12 | 가부시키가이샤 시세이도 | Method for producing o/w emulsion composition |
-
2012
- 2012-09-18 WO PCT/JP2012/073830 patent/WO2013061712A1/en active Application Filing
- 2012-09-18 JP JP2012204216A patent/JP5209816B1/en active Active
- 2012-09-27 TW TW101135479A patent/TW201318642A/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106456485A (en) * | 2014-04-21 | 2017-02-22 | 狮王株式会社 | Liquid composition for oral use and method for improving resilience to freezing thereof |
CN112272551A (en) * | 2018-06-20 | 2021-01-26 | 株式会社资生堂 | Oil-in-water emulsion composition and method for producing same |
Also Published As
Publication number | Publication date |
---|---|
WO2013061712A1 (en) | 2013-05-02 |
JP2013116884A (en) | 2013-06-13 |
TW201318642A (en) | 2013-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5209816B1 (en) | Method for producing O / W emulsion composition | |
EP2474296B1 (en) | Method for producing o/w emulsion composition | |
JP4767352B1 (en) | Emulsified composition | |
JP4824121B2 (en) | Topical skin preparation | |
ES2460878T3 (en) | Production process of an external oil-in-water microemulsion preparation | |
US20120164094A1 (en) | Production Method Of High-Viscosity O/W Cream | |
US20130331468A1 (en) | Production Method Of O/W Emulsion Composition | |
JP2007014866A (en) | Method for preparing oil in water microemulsion composition | |
JP2009126806A (en) | Method for producing high-molecular weight silicone-formulated microemulsion composition | |
JP5132800B1 (en) | Oil-in-water topical skin preparation | |
JP5243078B2 (en) | Highly polar oil-containing oil-in-water ultrafine emulsion external preparation and method for producing the oil-in-water ultrafine emulsion external preparation | |
JP5117208B2 (en) | Highly polar oil-containing oil-in-water ultrafine emulsion external preparation and method for producing the oil-in-water ultrafine emulsion external preparation | |
JP2008230994A (en) | Cosmetic | |
WO2020213660A1 (en) | O/d-type emulsion composition containing glycyrrhetinic acid, and oil-in-water-type emulsion composition | |
BR112020002821A2 (en) | emulsifying system, personal care product, method and use | |
JP7301826B2 (en) | Compounds suitable for personal care and cosmetic applications | |
JP2007269668A (en) | Oil-in-water whitening cosmetic | |
JP2004231581A (en) | Gel-like composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130219 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160301 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5209816 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |